WEBVTT - Ep 89 Hepatitis B: Hepatiti, Take 2

0:00:02.279 --> 0:00:06.360
<v Speaker 1>My name is su Wang. I am a physician. I'm

0:00:06.360 --> 0:00:10.280
<v Speaker 1>an MD MPH. I'm the medical director for the Center

0:00:10.320 --> 0:00:14.280
<v Speaker 1>for Asian Health and Viral Hepatitis Programs at the Cooperman

0:00:14.640 --> 0:00:19.799
<v Speaker 1>Barnabas Medical Center in New Jersey. And I'm also just

0:00:19.880 --> 0:00:24.000
<v Speaker 1>coming off a two year presidency for the World Hepatitis Alliance,

0:00:24.040 --> 0:00:29.360
<v Speaker 1>which is a nonprofit organization that represents patients living with

0:00:29.440 --> 0:00:32.880
<v Speaker 1>viral hepatitis. And our goal is to harness the power

0:00:32.920 --> 0:00:37.279
<v Speaker 1>of people living with viral hepatitis to achieve global elimination

0:00:37.360 --> 0:00:42.520
<v Speaker 1>of viral hepatitis. I was diagnosed with hepatitis B in college.

0:00:43.159 --> 0:00:46.040
<v Speaker 1>In my first year of college, I went to donate blood,

0:00:46.200 --> 0:00:51.120
<v Speaker 1>right to do a good thing, donate blood, and shortly

0:00:51.159 --> 0:00:54.200
<v Speaker 1>after I got a big, fat envelope sent to my

0:00:54.320 --> 0:00:58.960
<v Speaker 1>dorm and it said, don't be worried. You don't have HIV,

0:00:59.440 --> 0:01:03.120
<v Speaker 1>but you do have hepatitis B. And I was a

0:01:03.120 --> 0:01:05.919
<v Speaker 1>pre med student, but honestly I didn't know anything about

0:01:05.920 --> 0:01:09.800
<v Speaker 1>hep BEE. I called my sister, confided in her about

0:01:09.800 --> 0:01:12.240
<v Speaker 1>this new diagnosis, and she said, oh, didn't you know

0:01:12.480 --> 0:01:15.400
<v Speaker 1>Mom also has hep BE. And then I just I

0:01:15.440 --> 0:01:17.639
<v Speaker 1>just remember thinking, Oh, who do I need to tell

0:01:18.440 --> 0:01:20.840
<v Speaker 1>and when I went back home, I did go see

0:01:20.840 --> 0:01:23.920
<v Speaker 1>a doctor and talked to her about it, and I

0:01:23.959 --> 0:01:26.200
<v Speaker 1>think she did blood work and basically said I was

0:01:26.200 --> 0:01:28.319
<v Speaker 1>a carrier and there was nothing to worry about. So

0:01:28.600 --> 0:01:31.440
<v Speaker 1>I honestly pushed it to the back burner. Didn't want

0:01:31.440 --> 0:01:34.080
<v Speaker 1>to think about it, so it didn't come up again

0:01:34.160 --> 0:01:38.240
<v Speaker 1>until med school. I filled in all my med school

0:01:38.520 --> 0:01:41.640
<v Speaker 1>forms and a lot of our employment forms and our

0:01:41.720 --> 0:01:45.039
<v Speaker 1>screenings for working at a hospital. You do have to

0:01:45.400 --> 0:01:49.640
<v Speaker 1>indicate you know what your heppy vaccination and statuses. And

0:01:49.840 --> 0:01:53.440
<v Speaker 1>I had indicated that I was a carrier and didn't

0:01:53.760 --> 0:01:55.560
<v Speaker 1>hear anything about it. I didn't think anything of it.

0:01:55.600 --> 0:01:58.600
<v Speaker 1>And it's not untill now that I've heard numerous people

0:01:58.600 --> 0:02:00.919
<v Speaker 1>who are in med school found out to have happy

0:02:01.120 --> 0:02:04.600
<v Speaker 1>and actually they lose their acceptances to med school or

0:02:04.720 --> 0:02:06.919
<v Speaker 1>they faced quite a bit of what I would consider

0:02:07.000 --> 0:02:08.480
<v Speaker 1>discrimination over their status.

0:02:09.040 --> 0:02:09.160
<v Speaker 2>Uh.

0:02:09.320 --> 0:02:11.760
<v Speaker 1>And it's happened to residents, it's happened to nurses, it's

0:02:11.760 --> 0:02:15.200
<v Speaker 1>happened to dental students. So it is an issue of

0:02:15.320 --> 0:02:18.440
<v Speaker 1>stigma and discrimination. But I was fortunate it didn't happen

0:02:18.440 --> 0:02:20.560
<v Speaker 1>to me, and kind of was in the back of

0:02:20.560 --> 0:02:22.600
<v Speaker 1>my mind and I remember kind of when we learned

0:02:22.600 --> 0:02:25.200
<v Speaker 1>about hepatitis is kind of listening a little bit more attentively.

0:02:26.080 --> 0:02:29.880
<v Speaker 1>And when I got to residency after med school, I

0:02:29.880 --> 0:02:32.360
<v Speaker 1>became really good friends with somebody. A friend of mine

0:02:32.400 --> 0:02:36.400
<v Speaker 1>went into infectious disease, and I had confided in her

0:02:36.440 --> 0:02:39.520
<v Speaker 1>that I had happatitis B and she told me, oh,

0:02:39.520 --> 0:02:41.280
<v Speaker 1>make sure you see a doctor for it. I hadn't

0:02:41.280 --> 0:02:44.359
<v Speaker 1>seen a doctor in years at that point. So I

0:02:44.400 --> 0:02:47.840
<v Speaker 1>went in to see somebody and they did my viral

0:02:47.880 --> 0:02:50.480
<v Speaker 1>load and I did the ultrasound and everything was fine.

0:02:50.639 --> 0:02:53.600
<v Speaker 1>It was very low. I didn't need medication. And at

0:02:53.600 --> 0:02:56.320
<v Speaker 1>that point, I remember, I was engaged, I think, and

0:02:56.360 --> 0:02:59.280
<v Speaker 1>so my friend had said, oh, make sure your fiance

0:02:59.400 --> 0:03:03.040
<v Speaker 1>also gets to and he ended up getting tested and

0:03:03.080 --> 0:03:05.079
<v Speaker 1>needing to get vaccinated, and you know, so that was

0:03:05.160 --> 0:03:07.400
<v Speaker 1>kind of the extent of how it impacted my life.

0:03:07.440 --> 0:03:09.560
<v Speaker 1>And I had told him about it, and I was,

0:03:09.720 --> 0:03:11.680
<v Speaker 1>you know, I was happy that he was. He didn't

0:03:11.680 --> 0:03:13.680
<v Speaker 1>make a big deal out of it, and these are

0:03:13.680 --> 0:03:15.520
<v Speaker 1>all points Now looking back, I realized, you know, I

0:03:15.600 --> 0:03:17.880
<v Speaker 1>was fortunate, and so many people around the world are

0:03:17.919 --> 0:03:21.200
<v Speaker 1>not so fortunate to have, you know, a career that's

0:03:21.240 --> 0:03:25.000
<v Speaker 1>not affected by it, or a relationship that's not affected

0:03:25.000 --> 0:03:26.400
<v Speaker 1>by it. You know, there are a lot of people

0:03:26.440 --> 0:03:28.560
<v Speaker 1>who you know, lose their partners, they end up, they

0:03:28.639 --> 0:03:32.520
<v Speaker 1>may get divorced, they may get disowned by family or

0:03:32.680 --> 0:03:34.480
<v Speaker 1>unable to pursue the career they went to.

0:03:35.840 --> 0:03:36.480
<v Speaker 2>So I didn't have.

0:03:36.440 --> 0:03:41.000
<v Speaker 1>Any of that, and I got married and we got pregnant.

0:03:41.200 --> 0:03:44.320
<v Speaker 1>I've had four kids, and with each one of those kids,

0:03:44.400 --> 0:03:47.360
<v Speaker 1>especially the first one, it did hit me that, oh,

0:03:47.440 --> 0:03:49.200
<v Speaker 1>I know, there's a chance that I could pass this

0:03:49.240 --> 0:03:52.640
<v Speaker 1>affection on to my children, and that definitely weighed heavily

0:03:52.680 --> 0:03:55.120
<v Speaker 1>on me. Although I knew the research that because my

0:03:55.680 --> 0:03:58.680
<v Speaker 1>viral load was low, there would be very low chants

0:03:59.000 --> 0:04:02.960
<v Speaker 1>of the developing hep BE. But that's where I really

0:04:02.960 --> 0:04:04.560
<v Speaker 1>all of a sudden felt like, oh my gosh, you know,

0:04:04.640 --> 0:04:08.120
<v Speaker 1>this could really impact me personally. And I'm happy to

0:04:08.160 --> 0:04:10.040
<v Speaker 1>say that all for my kids are heap BE free

0:04:10.520 --> 0:04:12.280
<v Speaker 1>and that they don't have to live with this chronic

0:04:12.320 --> 0:04:15.080
<v Speaker 1>disease and worry about risk of lover cancer and other

0:04:15.120 --> 0:04:17.080
<v Speaker 1>things that other kids have to go through even now

0:04:17.120 --> 0:04:19.880
<v Speaker 1>in this day and age. And so as a physician,

0:04:19.920 --> 0:04:23.000
<v Speaker 1>I didn't particularly have an inkling that I was going

0:04:23.080 --> 0:04:26.040
<v Speaker 1>to do hepatitis work at all, And it wasn't until

0:04:26.120 --> 0:04:28.919
<v Speaker 1>I moved to New York City after I finished my

0:04:28.960 --> 0:04:32.280
<v Speaker 1>residency and I took a job with a community health

0:04:32.279 --> 0:04:36.600
<v Speaker 1>center in Chinatown. So I began serving the largely Chinese

0:04:36.640 --> 0:04:40.200
<v Speaker 1>community in Chinatown and learned so much more about HEPBE

0:04:40.200 --> 0:04:42.200
<v Speaker 1>than I ever knew. That it's, you know, one of

0:04:42.200 --> 0:04:46.480
<v Speaker 1>the most common infectious diseases around the world. Up to

0:04:46.600 --> 0:04:48.600
<v Speaker 1>like one in ten of our patients had heppy was

0:04:48.640 --> 0:04:52.560
<v Speaker 1>as common as hypertension. And whereas I had seen specialists,

0:04:52.640 --> 0:04:55.360
<v Speaker 1>you know, during residency, a lot of our patients could

0:04:55.360 --> 0:04:58.320
<v Speaker 1>not afford to see a specialist and they weren't necessarily

0:04:58.400 --> 0:05:01.360
<v Speaker 1>easily accessible. So many of us at the community health

0:05:01.360 --> 0:05:05.960
<v Speaker 1>center learned to treat hep BEE along with hypertension, diabetes,

0:05:06.000 --> 0:05:09.520
<v Speaker 1>and other chronic diseases. So during that time, I really saw,

0:05:09.920 --> 0:05:11.799
<v Speaker 1>you know, a lot of the difficulties that people face

0:05:11.920 --> 0:05:15.120
<v Speaker 1>and getting care, and so I began really advocating and

0:05:15.160 --> 0:05:18.160
<v Speaker 1>creating programs that would help people living with hepatitis. Be

0:05:18.680 --> 0:05:21.960
<v Speaker 1>to increase screening in the communities, linkage to care, all

0:05:21.960 --> 0:05:24.719
<v Speaker 1>these things that can happen in a very complex medical system.

0:05:25.400 --> 0:05:28.120
<v Speaker 1>We tried to create a program to kind of streamline

0:05:28.240 --> 0:05:30.200
<v Speaker 1>all of that. As I was getting more and more

0:05:30.240 --> 0:05:33.080
<v Speaker 1>immersed in, you know, really providing the care that needs

0:05:33.120 --> 0:05:36.159
<v Speaker 1>to happen, I really had the hat on, like, you know,

0:05:36.279 --> 0:05:38.760
<v Speaker 1>the physician hat, like this is what needs to be done,

0:05:39.279 --> 0:05:41.800
<v Speaker 1>these are the interventions, this is the science behind it.

0:05:42.279 --> 0:05:44.760
<v Speaker 1>I did not wear the patient hat at all in

0:05:44.839 --> 0:05:46.920
<v Speaker 1>terms of what it meant for me, and I kind

0:05:46.920 --> 0:05:49.599
<v Speaker 1>of didn't feel like that that was my role, and

0:05:49.640 --> 0:05:52.120
<v Speaker 1>it wasn't until somebody did an interview. Actually, I did

0:05:52.160 --> 0:05:54.920
<v Speaker 1>an interview for CDC, and it was the first time,

0:05:55.040 --> 0:05:56.920
<v Speaker 1>like on camera that I had I said, you know,

0:05:57.000 --> 0:06:00.240
<v Speaker 1>I'm actually living with hepatitis B myself. And at that

0:06:00.240 --> 0:06:02.960
<v Speaker 1>point I had already occasionally mentioned it to patients. So

0:06:03.040 --> 0:06:04.920
<v Speaker 1>if I was counseling a patient who had been newly

0:06:04.960 --> 0:06:06.919
<v Speaker 1>diagnosed with HEPPY and I could see they were really

0:06:06.920 --> 0:06:11.280
<v Speaker 1>distraught or felt really overwhelmed, I would share with them

0:06:11.320 --> 0:06:13.159
<v Speaker 1>that I also was living with hep BEE. I was

0:06:13.279 --> 0:06:15.120
<v Speaker 1>just like them. I had to go for blood tests,

0:06:15.279 --> 0:06:17.360
<v Speaker 1>and I think that really helped them see that it's

0:06:17.440 --> 0:06:21.039
<v Speaker 1>possible to live a happy, healthy life and it's not

0:06:21.080 --> 0:06:23.880
<v Speaker 1>a death sentence. So I was using that more often,

0:06:23.880 --> 0:06:26.960
<v Speaker 1>but I'd never spoken about it publicly, so it took

0:06:26.960 --> 0:06:27.480
<v Speaker 1>me a while.

0:06:27.680 --> 0:06:28.680
<v Speaker 2>And what I've seen.

0:06:28.440 --> 0:06:30.680
<v Speaker 1>As a physician, which I think as physicians we don't

0:06:30.760 --> 0:06:33.800
<v Speaker 1>quite get, is just how powerful that personal experience is.

0:06:34.720 --> 0:06:38.760
<v Speaker 1>And I have only learned this through other people. Somebody

0:06:38.760 --> 0:06:41.080
<v Speaker 1>asked me to get involved with the World Hepatitis Alliance,

0:06:41.080 --> 0:06:44.040
<v Speaker 1>which is led by patients, and through that on the board.

0:06:44.120 --> 0:06:47.000
<v Speaker 1>The board is all patients who represent each of the

0:06:47.080 --> 0:06:51.120
<v Speaker 1>WHO regions. And I heard specifically from a good friend

0:06:51.120 --> 0:06:52.560
<v Speaker 1>of mine who was now a good friend of my

0:06:52.680 --> 0:06:56.039
<v Speaker 1>d lee, who represented the Whippo region, the Western Pacific region.

0:06:56.200 --> 0:06:58.560
<v Speaker 1>He told me all these stories of people who really

0:06:59.040 --> 0:07:02.920
<v Speaker 1>had happy drastically empire their life in ways that us

0:07:02.920 --> 0:07:06.000
<v Speaker 1>in medicine don't measure, right. We measure the outcomes. We

0:07:06.040 --> 0:07:12.480
<v Speaker 1>look at our morbidity, mortality, life expectancy right soorrhosis, lever cancer.

0:07:13.280 --> 0:07:16.680
<v Speaker 1>We don't look at outcomes in terms of somebody's quality

0:07:16.720 --> 0:07:19.240
<v Speaker 1>of life. You know, when I hear these stories of

0:07:19.960 --> 0:07:23.920
<v Speaker 1>how people have suffered with the burden of the disease,

0:07:24.040 --> 0:07:26.400
<v Speaker 1>even if they are I mean, as a doctor, if

0:07:26.400 --> 0:07:28.120
<v Speaker 1>you were to look at them, they would look healthy.

0:07:28.600 --> 0:07:30.880
<v Speaker 1>You would tell them they're perfectly healthy, their liver enzymes

0:07:30.880 --> 0:07:33.280
<v Speaker 1>are normal, their viral load is low, like you know,

0:07:33.400 --> 0:07:34.960
<v Speaker 1>I only need to see you once a year, You're fine.

0:07:34.960 --> 0:07:36.640
<v Speaker 1>You know, in our mind we think it's we think

0:07:36.680 --> 0:07:39.280
<v Speaker 1>it's nothing like if you were to then delve into

0:07:39.320 --> 0:07:41.800
<v Speaker 1>how they feel about themselves, and most patients won't even

0:07:41.840 --> 0:07:44.080
<v Speaker 1>tell me that. So I know that what I see,

0:07:44.240 --> 0:07:47.400
<v Speaker 1>what I glimpse in my exam room is just such

0:07:47.400 --> 0:07:50.000
<v Speaker 1>a small part of what it means for them to

0:07:50.040 --> 0:07:52.600
<v Speaker 1>live with a disease. And so you know, it's beyond

0:07:52.800 --> 0:07:56.680
<v Speaker 1>just like keeping them from getting sorosis and liver cancer.

0:07:56.840 --> 0:07:59.360
<v Speaker 1>You know, us in medicine, if we're if our mission

0:07:59.440 --> 0:08:02.880
<v Speaker 1>is to prove quality of life and decrease burden of

0:08:02.920 --> 0:08:06.480
<v Speaker 1>disease on people's lives, we have to think outside just

0:08:06.640 --> 0:08:10.480
<v Speaker 1>you know, our our biochemical tests. I think, you know,

0:08:10.520 --> 0:08:12.720
<v Speaker 1>I've just learned that we can't afford to operate in

0:08:12.720 --> 0:08:16.160
<v Speaker 1>our silos. Right the scientists cannot afford to operate in

0:08:16.520 --> 0:08:19.720
<v Speaker 1>you know, their silos only like publishing to the scientific

0:08:19.720 --> 0:08:22.440
<v Speaker 1>community and having meetings that are only for scientists and

0:08:22.480 --> 0:08:25.440
<v Speaker 1>medical researchers. But we have to get out of the box.

0:08:25.480 --> 0:08:27.840
<v Speaker 1>We have to combine, you know, the people living with

0:08:27.880 --> 0:08:31.320
<v Speaker 1>the disease have to work in concert with the medical

0:08:31.320 --> 0:08:33.679
<v Speaker 1>community if we're really going to make progress for elimination

0:08:33.960 --> 0:08:37.000
<v Speaker 1>and for uh you know, really alleviating the suffering of

0:08:37.240 --> 0:09:14.880
<v Speaker 1>be on people's lives.

0:09:23.440 --> 0:09:26.400
<v Speaker 3>Thank you so much, doctor Wong for sharing your story.

0:09:26.920 --> 0:09:28.840
<v Speaker 2>Thank you. Hi.

0:09:29.040 --> 0:09:30.760
<v Speaker 4>I'm Aaron Welsh and.

0:09:30.720 --> 0:09:32.520
<v Speaker 2>I'm Aaron Alman Updyke.

0:09:32.679 --> 0:09:35.920
<v Speaker 3>And this is this podcast will Kill You.

0:09:36.040 --> 0:09:38.079
<v Speaker 2>Welcome to another episode.

0:09:38.480 --> 0:09:39.960
<v Speaker 4>Yes, welcome, Welcome.

0:09:40.880 --> 0:09:44.600
<v Speaker 3>As you have probably gathered, we are going to be

0:09:44.679 --> 0:09:50.040
<v Speaker 3>talking about another hepatitis virus, our second podcast history.

0:09:50.280 --> 0:09:54.319
<v Speaker 2>Yes, this one hepatitis B. Yeah, we started with C.

0:09:54.760 --> 0:09:58.480
<v Speaker 2>Now we're going to be what's next? Uh, well, I

0:09:58.520 --> 0:10:04.120
<v Speaker 2>am going to mention D. I've figured I think next

0:10:04.160 --> 0:10:04.560
<v Speaker 2>will be A.

0:10:05.240 --> 0:10:08.800
<v Speaker 3>Yeah, next will definitely be A, and then we'll have

0:10:08.840 --> 0:10:10.679
<v Speaker 3>to do E and then maybe by the time that

0:10:10.720 --> 0:10:12.000
<v Speaker 3>comes out, there'll be a few.

0:10:11.760 --> 0:10:17.520
<v Speaker 4>More and we can cover all in one quite possible. Well, Aaron,

0:10:18.040 --> 0:10:19.040
<v Speaker 4>what time is it?

0:10:19.040 --> 0:10:21.119
<v Speaker 2>It's quarantiny time, Aaron.

0:10:21.280 --> 0:10:24.400
<v Speaker 4>It is. And what are we drinking this week?

0:10:24.559 --> 0:10:26.359
<v Speaker 2>We're drinking the beasting.

0:10:27.000 --> 0:10:30.280
<v Speaker 3>We are appatitis B, hepatitis B.

0:10:30.880 --> 0:10:32.560
<v Speaker 4>And what is in the beasting?

0:10:33.120 --> 0:10:37.440
<v Speaker 2>Well, It's a lovely little bev a ginger mint syrup,

0:10:37.960 --> 0:10:42.560
<v Speaker 2>some lemon juice, club soda. If you're drinking alcohol, you

0:10:42.600 --> 0:10:44.120
<v Speaker 2>could certainly put some gin in it.

0:10:44.520 --> 0:10:48.160
<v Speaker 3>That will be the little sting, But otherwise on its own,

0:10:48.800 --> 0:10:51.719
<v Speaker 3>it is delicious, very refreshing.

0:10:52.200 --> 0:10:53.600
<v Speaker 4>I just I love it.

0:10:55.080 --> 0:10:58.880
<v Speaker 3>And we will post the full recipe for this quarantini

0:10:59.040 --> 0:11:01.960
<v Speaker 3>as well as our non alcoholic Placey Brita on our

0:11:01.960 --> 0:11:05.000
<v Speaker 3>website This Podcast will Kill You dot com, as well

0:11:05.040 --> 0:11:06.960
<v Speaker 3>as on all of our social media channels.

0:11:07.520 --> 0:11:10.120
<v Speaker 2>On our website This Podcast will Kill You dot Com,

0:11:10.600 --> 0:11:13.520
<v Speaker 2>you will find any and every of the things that

0:11:13.559 --> 0:11:16.120
<v Speaker 2>you ever wanted to know about the podcast. You can

0:11:16.160 --> 0:11:19.320
<v Speaker 2>find Bloodmobile, who does all of our music, and the

0:11:19.360 --> 0:11:23.200
<v Speaker 2>link to their Spotify. You can find merch all of

0:11:23.240 --> 0:11:27.240
<v Speaker 2>our merch. You can find transcripts for all of our episodes.

0:11:27.480 --> 0:11:32.040
<v Speaker 2>You can find a bookshop dot org affiliate account, and

0:11:32.520 --> 0:11:35.079
<v Speaker 2>a good Reads list. You can find all you're doing

0:11:35.120 --> 0:11:37.360
<v Speaker 2>great things for all of our episodes. Thanks. I need

0:11:37.400 --> 0:11:41.360
<v Speaker 2>the encouragement, and you can find our Patreon.

0:11:41.640 --> 0:11:45.160
<v Speaker 3>Wow, that was impressive.

0:11:45.320 --> 0:11:46.160
<v Speaker 2>Thank you. Thanks.

0:11:46.400 --> 0:11:48.400
<v Speaker 4>I'm always relieved when I don't have to do it.

0:11:49.040 --> 0:11:51.959
<v Speaker 2>I always get really nervous and then I just power through.

0:11:52.400 --> 0:11:53.160
<v Speaker 4>I like it.

0:11:53.160 --> 0:11:55.200
<v Speaker 3>It's like you get in the zone and then you're there.

0:11:57.679 --> 0:12:02.000
<v Speaker 3>Well before we get into the episode, I wanted to

0:12:02.080 --> 0:12:06.120
<v Speaker 3>mention one thing because Endometriosis, which was the last episode

0:12:06.120 --> 0:12:09.520
<v Speaker 3>we released, is still on my mind. Even though I've

0:12:09.559 --> 0:12:12.680
<v Speaker 3>been reading a lot about happatitis B, I still have

0:12:12.800 --> 0:12:16.640
<v Speaker 3>these like little thoughts of endo that pop in, and

0:12:16.720 --> 0:12:19.760
<v Speaker 3>I realized that there was like one more thing that

0:12:19.840 --> 0:12:24.120
<v Speaker 3>I wanted to say. Also, like endometriosis, we've recorded it,

0:12:24.120 --> 0:12:28.040
<v Speaker 3>it's not yet released, and so maybe people will have

0:12:28.120 --> 0:12:30.160
<v Speaker 3>already said this by the time this comes out. It's

0:12:30.160 --> 0:12:33.360
<v Speaker 3>sort of a weird time travel thing we're doing here. Yeah,

0:12:33.400 --> 0:12:37.240
<v Speaker 3>But in the endometriosis episode, we talked about how often

0:12:37.520 --> 0:12:42.120
<v Speaker 3>complete or partial hysterectomy is recommended as like a cure

0:12:42.720 --> 0:12:47.520
<v Speaker 3>for endometriosis, which it isn't, and which that can also

0:12:47.679 --> 0:12:50.840
<v Speaker 3>add another dimension of pain and anguish to an already

0:12:50.840 --> 0:12:55.400
<v Speaker 3>difficult disease. But I also think that another aspect to

0:12:55.600 --> 0:12:57.960
<v Speaker 3>that that we didn't really touch on, and I think

0:12:58.040 --> 0:13:00.920
<v Speaker 3>is important to mention, is that there can also be

0:13:00.960 --> 0:13:05.400
<v Speaker 3>a reluctance on the part of physicians to perform hysterectomies,

0:13:05.520 --> 0:13:08.240
<v Speaker 3>or even just tubal ligations, like getting your tubes tied

0:13:08.679 --> 0:13:11.680
<v Speaker 3>for whatever reason. Even if that reason is I don't

0:13:11.720 --> 0:13:14.960
<v Speaker 3>want to have any children or any more children, a

0:13:14.960 --> 0:13:17.959
<v Speaker 3>lot of people are just told, oh, you're just too young.

0:13:18.040 --> 0:13:19.760
<v Speaker 3>You might change your mind and want to have kids

0:13:19.760 --> 0:13:22.199
<v Speaker 3>in the future. And so really that's sort of another

0:13:22.280 --> 0:13:25.320
<v Speaker 3>way in which many times physicians don't fulfill the very

0:13:25.360 --> 0:13:28.280
<v Speaker 3>basic requirement of listening to their patient and how the

0:13:28.320 --> 0:13:31.559
<v Speaker 3>social and gender role of someone can be held as

0:13:31.840 --> 0:13:37.200
<v Speaker 3>more important than what they want than their wishes. Yeah, anyway,

0:13:37.200 --> 0:13:39.240
<v Speaker 3>that just kept like circulating in my head and I

0:13:39.280 --> 0:13:40.840
<v Speaker 3>was like, oh, gosh, I need to say it.

0:13:42.480 --> 0:13:45.080
<v Speaker 4>So yeah, okay, got it out.

0:13:45.440 --> 0:13:48.440
<v Speaker 2>Yeah, that's an incredibly important point.

0:13:49.200 --> 0:13:53.800
<v Speaker 3>Okay, should we move on to the actual topic of

0:13:53.840 --> 0:13:54.600
<v Speaker 3>today's episode.

0:13:54.679 --> 0:13:58.920
<v Speaker 2>Today's topic hepatitis B. Let's take a quick break and

0:13:58.960 --> 0:14:34.920
<v Speaker 2>then get into the biology. So, like you mentioned erin,

0:14:35.320 --> 0:14:39.760
<v Speaker 2>this is our second hepatitis virus. And I know for

0:14:39.840 --> 0:14:43.480
<v Speaker 2>sure that during our hepatitis C episode we talked at

0:14:43.560 --> 0:14:50.080
<v Speaker 2>least a little bit about how all the hepatiti all

0:14:50.120 --> 0:14:53.760
<v Speaker 2>the hepatitis viruses are named, not for anything that links

0:14:53.800 --> 0:14:57.240
<v Speaker 2>the particular viruses together, aside from the fact that they

0:14:57.280 --> 0:15:02.720
<v Speaker 2>all predominantly affect the liver. So there are five predominant

0:15:02.760 --> 0:15:06.280
<v Speaker 2>viruses which we kind of already named at the beginning, A, B, C, D,

0:15:06.400 --> 0:15:11.160
<v Speaker 2>and E. And today we're focusing on hepatitis B, and

0:15:11.240 --> 0:15:14.640
<v Speaker 2>I will mention hepatitis D and you'll understand why in

0:15:14.680 --> 0:15:19.080
<v Speaker 2>a minute if you don't already know the little interplay

0:15:19.120 --> 0:15:24.680
<v Speaker 2>between hepatitis D and B. All right, hepatitis B. It's

0:15:24.720 --> 0:15:30.880
<v Speaker 2>in the family Hepadnaviridae, which essentially just means viruses that

0:15:30.920 --> 0:15:35.520
<v Speaker 2>affect the liver, like no surprise, straightforward. One thing that's

0:15:35.800 --> 0:15:38.200
<v Speaker 2>there's a lot of interesting things about the virology of

0:15:38.280 --> 0:15:40.520
<v Speaker 2>hepatitis B, and I'm probably not even going to do

0:15:40.560 --> 0:15:45.280
<v Speaker 2>them justice, but here we try. Hepatitis B virus is

0:15:45.360 --> 0:15:50.880
<v Speaker 2>a partially double stranded DNA virus, which is weird. So

0:15:50.960 --> 0:15:54.280
<v Speaker 2>it has a genome that it's like in a little circle,

0:15:54.880 --> 0:15:57.600
<v Speaker 2>and part of it is double stranded and part of

0:15:57.600 --> 0:16:00.920
<v Speaker 2>it is single stranded, which is very bizarre. Do you

0:16:00.920 --> 0:16:02.520
<v Speaker 2>have a question already? Erin, I can.

0:16:02.440 --> 0:16:06.600
<v Speaker 3>See an I mean yes, but I'm waiting being patient.

0:16:06.760 --> 0:16:11.200
<v Speaker 2>Okay, we'll see if I have any answers. Hepatitis B

0:16:11.320 --> 0:16:14.960
<v Speaker 2>virus has a lot of different genotypes that vary vary

0:16:15.040 --> 0:16:19.960
<v Speaker 2>widely in their overall geographic distribution. However, as we mentioned

0:16:20.040 --> 0:16:22.480
<v Speaker 2>up top, and as we'll talk a lot about towards

0:16:22.480 --> 0:16:25.840
<v Speaker 2>the end of this episode, this is a globally distributed,

0:16:26.320 --> 0:16:33.960
<v Speaker 2>incredibly prevalent virus, like incredibly incredibly prevalent, and it's still,

0:16:34.040 --> 0:16:36.000
<v Speaker 2>as far as I can tell a little bit up

0:16:36.040 --> 0:16:39.600
<v Speaker 2>for debate whether these different genotypes really vary in their

0:16:39.640 --> 0:16:43.320
<v Speaker 2>tendency to cause chronic infection or in their overall disease course.

0:16:43.640 --> 0:16:46.160
<v Speaker 2>A lot of sources I read said that yes, different

0:16:46.200 --> 0:16:49.400
<v Speaker 2>genotypes kind of have different tendencies or characteristics, and some

0:16:49.520 --> 0:16:54.840
<v Speaker 2>said it's up for debate, so okay. But being a virus,

0:16:55.080 --> 0:16:57.480
<v Speaker 2>this is of course a pathogen that has to find

0:16:57.520 --> 0:17:00.920
<v Speaker 2>its way into our cells, and being a virus that

0:17:00.960 --> 0:17:04.920
<v Speaker 2>infects the liver, it's unsurprising that the primary cell type

0:17:04.960 --> 0:17:09.200
<v Speaker 2>that it infects is our hepatocites, our actual liver cells,

0:17:09.960 --> 0:17:12.919
<v Speaker 2>not the blood vessels in our liver, not any of

0:17:12.960 --> 0:17:17.600
<v Speaker 2>the other things around there, but generally our liver cells.

0:17:17.640 --> 0:17:20.760
<v Speaker 3>The things that make up the meat of the liver.

0:17:20.920 --> 0:17:25.680
<v Speaker 2>Exactly, also called the paranama of the liver, the fancy

0:17:25.720 --> 0:17:32.600
<v Speaker 2>word for the meat. So hepatitis B is transmitted in

0:17:32.760 --> 0:17:36.520
<v Speaker 2>very similar ways to hepatitis C, as you may remember

0:17:36.560 --> 0:17:42.520
<v Speaker 2>from several seasons ago now, but with a few important caveats. So,

0:17:42.600 --> 0:17:46.800
<v Speaker 2>hepatitis B can be a blood born virus, So anything

0:17:46.800 --> 0:17:50.520
<v Speaker 2>that involves the sharing of blood, whether that's contaminated needles

0:17:51.119 --> 0:17:55.080
<v Speaker 2>in the healthcare setting or in intravenous drug use settings,

0:17:55.960 --> 0:17:59.200
<v Speaker 2>it can be transmitted via blood transfusions, and of course

0:17:59.320 --> 0:18:01.119
<v Speaker 2>is something that we see screen for to try and

0:18:01.119 --> 0:18:01.640
<v Speaker 2>reduce the.

0:18:01.640 --> 0:18:02.119
<v Speaker 4>Risk of that.

0:18:03.440 --> 0:18:08.200
<v Speaker 2>But hepatitis B is also much more easily transmitted sexually

0:18:08.240 --> 0:18:13.119
<v Speaker 2>compared to hepatitis C. It's present in so many bodily fluids.

0:18:13.680 --> 0:18:14.640
<v Speaker 4>Why is that?

0:18:15.400 --> 0:18:20.080
<v Speaker 2>It's a really good question. I imagine it is largely

0:18:20.119 --> 0:18:25.000
<v Speaker 2>because hepatitis B is very, very infectious. As an example,

0:18:26.000 --> 0:18:30.160
<v Speaker 2>according to WHO, it's fifty to one hundred times more

0:18:30.240 --> 0:18:33.159
<v Speaker 2>infectious than HIV WHOA.

0:18:33.440 --> 0:18:37.160
<v Speaker 3>So I know, do we know the reasons for that

0:18:37.480 --> 0:18:39.320
<v Speaker 3>increased infectivity.

0:18:39.720 --> 0:18:43.800
<v Speaker 2>Oh, that's a very good question. I do not, Okay, yeah,

0:18:43.840 --> 0:18:46.479
<v Speaker 2>And I don't also have numbers on like the actual

0:18:46.560 --> 0:18:49.920
<v Speaker 2>infectious dose. I couldn't find a solid answer on that. Either.

0:18:51.000 --> 0:18:53.600
<v Speaker 2>I do know that it can persist in the environment

0:18:53.880 --> 0:18:56.119
<v Speaker 2>for at least several days, so I think it's a

0:18:56.160 --> 0:18:59.440
<v Speaker 2>pretty hardy virus, So that might be part of it.

0:18:59.560 --> 0:19:06.000
<v Speaker 3>Yeah, Okay, So going back real quick, partially double stranded,

0:19:06.080 --> 0:19:09.399
<v Speaker 3>what's the implication of that in like a virology sense.

0:19:09.480 --> 0:19:12.760
<v Speaker 2>So it's really interesting. Hepatitis B is one of the

0:19:12.840 --> 0:19:16.800
<v Speaker 2>few viruses that's not an RNA virus but uses a

0:19:17.040 --> 0:19:21.040
<v Speaker 2>reverse transcriptase in order to replicate its genome. So HIV

0:19:21.560 --> 0:19:25.560
<v Speaker 2>is an RNA virus that relies on an enzyme reverse

0:19:25.600 --> 0:19:29.840
<v Speaker 2>transcriptase to make a form of DNA in order to

0:19:29.880 --> 0:19:34.399
<v Speaker 2>then replicate, and B also does even though it's a

0:19:34.520 --> 0:19:35.480
<v Speaker 2>DNA virus.

0:19:36.280 --> 0:19:39.080
<v Speaker 3>That is so bizarre, and so I definitely came across

0:19:39.080 --> 0:19:42.440
<v Speaker 3>some of that in the evolution behabers because it kind

0:19:42.440 --> 0:19:44.679
<v Speaker 3>of throws a wrench in things as to like the

0:19:44.800 --> 0:19:47.960
<v Speaker 3>mutation rates, the scale of the molecular clock, blah blah

0:19:47.960 --> 0:19:48.640
<v Speaker 3>blahh Yeah.

0:19:48.640 --> 0:19:50.680
<v Speaker 2>And it also, as I'll kind of talk a little

0:19:50.720 --> 0:19:53.800
<v Speaker 2>bit more about later, it allows it to integrate into

0:19:53.840 --> 0:19:57.040
<v Speaker 2>our genome in a way that then sets us up

0:19:57.200 --> 0:20:02.080
<v Speaker 2>for both chronic infection and also potentially cancer right and

0:20:02.119 --> 0:20:05.720
<v Speaker 2>cancer causing mutations. Ahah, spoilers.

0:20:06.600 --> 0:20:13.199
<v Speaker 3>Do other viruses have this partially double stranded DNA thing

0:20:14.000 --> 0:20:14.520
<v Speaker 3>as well?

0:20:14.680 --> 0:20:17.080
<v Speaker 2>I don't know of any other human viruses, but I

0:20:17.119 --> 0:20:19.840
<v Speaker 2>know that there are other animal hepatnaviruses that do.

0:20:19.880 --> 0:20:24.119
<v Speaker 3>Right, Okay, those so that's like the unifying future of hepatnaviruses.

0:20:24.160 --> 0:20:26.639
<v Speaker 2>Okay, yeah, yeah, wow?

0:20:26.800 --> 0:20:27.080
<v Speaker 4>Cool?

0:20:28.080 --> 0:20:32.639
<v Speaker 2>Okay. So hepatitis B is also transmitted back to that

0:20:32.720 --> 0:20:36.280
<v Speaker 2>part of it vertically at much higher rates.

0:20:36.760 --> 0:20:36.920
<v Speaker 3>This.

0:20:37.640 --> 0:20:39.679
<v Speaker 2>Let me tell you some numbers. The estimates that I

0:20:39.720 --> 0:20:44.920
<v Speaker 2>read ranged from forty to ninety percent of babies born

0:20:45.000 --> 0:20:48.159
<v Speaker 2>to people living with hepatitis B, with chronic hepatitis B

0:20:48.880 --> 0:20:52.960
<v Speaker 2>will become infected with hepatitis if they are not treated.

0:20:53.440 --> 0:20:54.000
<v Speaker 4>Wow.

0:20:54.160 --> 0:20:58.040
<v Speaker 2>And this is in comparison to only six percent of

0:20:58.160 --> 0:21:02.199
<v Speaker 2>people with hepatitis C will then transmit hepatitis C to

0:21:02.280 --> 0:21:03.000
<v Speaker 2>their offspring.

0:21:03.800 --> 0:21:06.359
<v Speaker 3>What is the reason for that difference?

0:21:06.720 --> 0:21:11.520
<v Speaker 2>Again, I think it's largely just how infectious hepatitis B is. Okay,

0:21:11.840 --> 0:21:14.560
<v Speaker 2>but here's something that I think is very interesting and

0:21:15.080 --> 0:21:20.080
<v Speaker 2>important about this vertical transmission of hepatitis B. First of all,

0:21:20.160 --> 0:21:22.639
<v Speaker 2>a lot of times when we talk about vertical transmissions,

0:21:22.680 --> 0:21:27.520
<v Speaker 2>so from parent to offspring, it's wind viruses or bacteria

0:21:27.760 --> 0:21:32.239
<v Speaker 2>can cross the placenta and infective fetus during pregnancy. That

0:21:32.359 --> 0:21:35.800
<v Speaker 2>is not what happens in hepatitis B. The transmission is

0:21:35.840 --> 0:21:40.800
<v Speaker 2>not transplacental. In the vast, vast majority of cases, it's

0:21:40.960 --> 0:21:45.760
<v Speaker 2>happening during the process of childbirth, and it's not happening

0:21:46.080 --> 0:21:50.639
<v Speaker 2>during breastfeeding. It's not happening during pregnancy crossing the placenta.

0:21:50.720 --> 0:21:56.560
<v Speaker 2>It's happening specifically during the period of childbirth, whether that

0:21:56.680 --> 0:22:02.399
<v Speaker 2>birth happens vaginally or VC section. What there is some

0:22:02.600 --> 0:22:05.520
<v Speaker 2>papers that suggest that C section delivery is a slightly

0:22:05.760 --> 0:22:10.680
<v Speaker 2>lower risk, but it's not conclusive. And if you've ever

0:22:10.720 --> 0:22:13.720
<v Speaker 2>seen a delivery of either kind, it kind of makes

0:22:13.760 --> 0:22:17.200
<v Speaker 2>sense because neither one is really less bloody than the other,

0:22:17.640 --> 0:22:20.760
<v Speaker 2>and so many bodily fluids are being exchanged no matter

0:22:20.840 --> 0:22:22.440
<v Speaker 2>what exit root a baby takes.

0:22:22.840 --> 0:22:25.920
<v Speaker 3>It's so it's just like the blood and bodily fluids.

0:22:25.560 --> 0:22:29.560
<v Speaker 2>Blood bodily fluids. It's thought that cervical secretions, so if

0:22:29.560 --> 0:22:32.240
<v Speaker 2>a baby comes out vaginally, and that's why maybe there's

0:22:32.240 --> 0:22:34.840
<v Speaker 2>some thought that it's a slightly higher risk, but the

0:22:34.920 --> 0:22:37.080
<v Speaker 2>data hasn't really borne that out necessarily.

0:22:38.600 --> 0:22:42.280
<v Speaker 3>What that's very interesting, I know, because I didn't really

0:22:42.320 --> 0:22:42.920
<v Speaker 3>realize that.

0:22:43.000 --> 0:22:44.840
<v Speaker 2>I kind of thought that it was something that could

0:22:44.840 --> 0:22:49.720
<v Speaker 2>be transmitted transpolacentally. Yet it's not, and that is really

0:22:49.800 --> 0:22:53.600
<v Speaker 2>important when we talk about how to treat and prevent

0:22:54.080 --> 0:22:57.800
<v Speaker 2>hepatitis B infection. So let me keep going, shall I?

0:22:58.960 --> 0:23:03.120
<v Speaker 2>You shall The incubation period of infection, the time from

0:23:03.240 --> 0:23:07.360
<v Speaker 2>when someone gets infected to when they show symptoms, can

0:23:07.440 --> 0:23:12.200
<v Speaker 2>really range anywhere from thirty days to up to six months.

0:23:13.760 --> 0:23:17.280
<v Speaker 2>And I think that this incubation period, even noting it

0:23:17.359 --> 0:23:22.440
<v Speaker 2>incubation period, is interesting because hepatitis B is a virus

0:23:22.520 --> 0:23:27.960
<v Speaker 2>that can be entirely asymptomatic, and chronic infection is generally

0:23:28.000 --> 0:23:32.000
<v Speaker 2>defined as the persistence of a specific anigen being able

0:23:32.040 --> 0:23:36.600
<v Speaker 2>to detect hepatitis B surface antigen for a period of

0:23:36.640 --> 0:23:40.119
<v Speaker 2>at least six months. So it's interesting that you can

0:23:40.160 --> 0:23:43.280
<v Speaker 2>also say the incubation period itself might be six months

0:23:43.320 --> 0:23:47.000
<v Speaker 2>before you show symptoms, but you also might never show symptoms.

0:23:47.800 --> 0:23:48.080
<v Speaker 4>Yeah.

0:23:48.640 --> 0:23:53.159
<v Speaker 3>Yeah, that makes it really difficult to calculate an incubation exactly.

0:23:53.200 --> 0:23:53.919
<v Speaker 3>It sure does.

0:23:56.320 --> 0:23:59.800
<v Speaker 2>So let's talk briefly about what the symptoms can be

0:24:00.520 --> 0:24:04.080
<v Speaker 2>if people do have kind of an acute infection or

0:24:04.800 --> 0:24:09.360
<v Speaker 2>you know, symptoms with an initial infection. Most of the time,

0:24:09.400 --> 0:24:14.280
<v Speaker 2>of course, it's completely asymptomatic or very minimally symptomatic. And

0:24:14.480 --> 0:24:18.199
<v Speaker 2>it's important to note that some people can clear the

0:24:18.280 --> 0:24:22.639
<v Speaker 2>virus entirely from their system after an acute infection, whether

0:24:22.680 --> 0:24:27.240
<v Speaker 2>they show symptoms or not. But we'll talk about how

0:24:27.280 --> 0:24:29.160
<v Speaker 2>that doesn't happen for a lot of people and who

0:24:29.160 --> 0:24:32.760
<v Speaker 2>those people are and why. Okay, okay, But when symptoms

0:24:32.800 --> 0:24:36.680
<v Speaker 2>do occur in the case of an acute infection, they

0:24:37.000 --> 0:24:39.840
<v Speaker 2>really don't look any different from a lot of the

0:24:40.000 --> 0:24:44.639
<v Speaker 2>other viruses and pathogens that affect our liver, including hepatitis C.

0:24:45.840 --> 0:24:49.520
<v Speaker 2>So hepatitis B is less likely to cause acute liver

0:24:49.760 --> 0:24:55.560
<v Speaker 2>failure completely, but it can cause things like jaundice where

0:24:55.720 --> 0:24:58.120
<v Speaker 2>your skin can become yellow, or the whites of your

0:24:58.160 --> 0:25:02.040
<v Speaker 2>eyes and your gums, things like that that become yellowish.

0:25:02.119 --> 0:25:05.719
<v Speaker 2>And this occurs because our liver is what conjugates and

0:25:05.760 --> 0:25:11.240
<v Speaker 2>helps eliminate bilirubin from our bodies, and so without that process, bilirubin,

0:25:11.359 --> 0:25:13.879
<v Speaker 2>which is a breakdown product of our red blood cells,

0:25:14.560 --> 0:25:17.120
<v Speaker 2>builds up in our skin and our eyes, and that's

0:25:17.160 --> 0:25:21.240
<v Speaker 2>what turns us yellow. It then also causes a lot

0:25:21.280 --> 0:25:25.000
<v Speaker 2>of nausea and vomiting from this buildup of not just bilirubin,

0:25:25.040 --> 0:25:27.840
<v Speaker 2>but a lot of stuff in our system that our

0:25:27.880 --> 0:25:32.000
<v Speaker 2>liver is supposed to filter out. It causes abdominal pain

0:25:32.200 --> 0:25:35.760
<v Speaker 2>because your liver is inflamed, and even though your liver

0:25:35.840 --> 0:25:40.000
<v Speaker 2>itself doesn't have sensory innervation, this inflammation can reach the

0:25:40.080 --> 0:25:43.200
<v Speaker 2>lining of the liver, the lining of the abdominal cavity

0:25:43.240 --> 0:25:47.719
<v Speaker 2>and cause pretty severe abdominal pain. And then all of

0:25:47.760 --> 0:25:51.560
<v Speaker 2>these toxins that can accumulate in your bloodstream can cause

0:25:51.600 --> 0:25:55.119
<v Speaker 2>severe fatigue. It can cause a darkening of your urine

0:25:55.160 --> 0:25:57.960
<v Speaker 2>as the bilirubin tries to be excreted through your urine

0:25:58.000 --> 0:26:02.439
<v Speaker 2>instead of your poop, and in very rare cases, it

0:26:02.480 --> 0:26:07.080
<v Speaker 2>can cause actual acute onset liver failure, which can be fatal,

0:26:08.119 --> 0:26:13.040
<v Speaker 2>but much more commonly, liver failure happens as a progressive

0:26:13.119 --> 0:26:20.560
<v Speaker 2>process of long term inflammation, leading to cirrhosis and fibrosis

0:26:21.040 --> 0:26:27.439
<v Speaker 2>and potentially hepatocellular carcinoma or cancer. So I want to

0:26:27.480 --> 0:26:32.560
<v Speaker 2>focus on this, this chronic infection of hepatitis B, because

0:26:33.320 --> 0:26:35.720
<v Speaker 2>it's not only very interesting but it's also the most

0:26:35.720 --> 0:26:41.320
<v Speaker 2>important part of this virus. So, first of all, the

0:26:41.680 --> 0:26:48.560
<v Speaker 2>likelihood of a chronic infection becoming established varies person to person,

0:26:49.440 --> 0:26:53.320
<v Speaker 2>and it's inversely related to the age at which you

0:26:53.400 --> 0:26:59.640
<v Speaker 2>become exposed and infected. So for infants, for neonates who

0:26:59.640 --> 0:27:04.600
<v Speaker 2>get infected vertically during birth, the likelihood of a chronic

0:27:04.720 --> 0:27:12.159
<v Speaker 2>infection is over ninety percent over ninety percent, So that

0:27:12.280 --> 0:27:16.480
<v Speaker 2>means that almost all babies that become infected at birth

0:27:16.560 --> 0:27:20.720
<v Speaker 2>or shortly thereafter go on to have a chronic lifelong

0:27:20.880 --> 0:27:25.600
<v Speaker 2>infection with a very significant risk of progression to fibrosis

0:27:26.080 --> 0:27:28.160
<v Speaker 2>and or liver cancer.

0:27:28.840 --> 0:27:32.560
<v Speaker 3>So this inverse relationship, is it like a straight line

0:27:32.800 --> 0:27:34.880
<v Speaker 3>or does it kind of have any sort of peaks

0:27:34.920 --> 0:27:35.600
<v Speaker 3>and valleys?

0:27:35.680 --> 0:27:40.439
<v Speaker 2>It's not a straight line. It's a it's a well,

0:27:40.560 --> 0:27:44.160
<v Speaker 2>what do you call it? No, it's a what a zoop? Maybe?

0:27:44.320 --> 0:27:46.040
<v Speaker 4>What do you call it? Sigmore a jay?

0:27:46.560 --> 0:27:50.280
<v Speaker 2>So let me just tell you numbers, because I'm clearly

0:27:50.320 --> 0:27:56.800
<v Speaker 2>not doing a good job swooping. So infant neonate ninety

0:27:56.840 --> 0:28:00.439
<v Speaker 2>percent chance a child if they get in afected when

0:28:00.440 --> 0:28:03.320
<v Speaker 2>they're young, like between ages one to five, the risk

0:28:03.400 --> 0:28:06.159
<v Speaker 2>of chronic infection is like thirty percent, so it's a

0:28:06.160 --> 0:28:09.639
<v Speaker 2>pretty big drop. And then it's a little lower for

0:28:09.760 --> 0:28:13.320
<v Speaker 2>older children and for adults. If you don't get infected

0:28:13.400 --> 0:28:16.360
<v Speaker 2>until you are an adult, the risk of chronic infection

0:28:16.600 --> 0:28:20.960
<v Speaker 2>is only about two to five percent, so substantially lower.

0:28:21.480 --> 0:28:24.560
<v Speaker 4>Hmm. I mean, okay, I have to ask why.

0:28:25.200 --> 0:28:29.520
<v Speaker 2>I'm glad you asked Aaron, Let's talk about it. But

0:28:29.680 --> 0:28:33.600
<v Speaker 2>first let me also say that even though the risk

0:28:33.680 --> 0:28:37.160
<v Speaker 2>of chronic infection if you get infected as an adult

0:28:37.680 --> 0:28:43.320
<v Speaker 2>is low, the chronic infection itself and the like prognosis

0:28:43.360 --> 0:28:47.120
<v Speaker 2>of a chronic infection with hepatitis B in general is

0:28:47.280 --> 0:28:51.280
<v Speaker 2>worse than, for example, the chronic infection of hepatitis C.

0:28:51.920 --> 0:28:54.640
<v Speaker 2>And if you listened to our hepatitis C episode, then

0:28:54.680 --> 0:28:58.200
<v Speaker 2>you remember hepatitis C is not a good virus, right,

0:28:59.600 --> 0:29:04.160
<v Speaker 2>But in hepatitis C, the likelihood of a chronic infection

0:29:04.360 --> 0:29:07.760
<v Speaker 2>is much higher for adults across the board. But the

0:29:07.880 --> 0:29:12.000
<v Speaker 2>rate of for example, liver cancer is very low, like

0:29:12.040 --> 0:29:16.680
<v Speaker 2>two point five percent for people who have chronic hepatitis C. Right,

0:29:16.760 --> 0:29:19.960
<v Speaker 2>But much more people who get infected as adults with

0:29:20.040 --> 0:29:22.080
<v Speaker 2>HEPSI go on to get chronic HEPSI.

0:29:22.920 --> 0:29:24.160
<v Speaker 4>That makes sense.

0:29:24.480 --> 0:29:28.760
<v Speaker 3>Yeah, like, okay, in the numbers perspective, right, But.

0:29:28.680 --> 0:29:33.920
<v Speaker 2>For hepatitis B, fifteen to forty percent of people who

0:29:34.000 --> 0:29:40.600
<v Speaker 2>have chronic infection go on to have liver cancer, hepatocellular carcinoma.

0:29:41.360 --> 0:29:42.960
<v Speaker 2>It's a huge percentage.

0:29:43.320 --> 0:29:43.720
<v Speaker 4>Yeah.

0:29:43.760 --> 0:29:49.440
<v Speaker 2>And again, ninety percent of infants who become infected go

0:29:49.560 --> 0:29:52.480
<v Speaker 2>on to have chronic infection. So that's major.

0:29:53.120 --> 0:29:56.120
<v Speaker 4>That's a really disturbingly.

0:29:55.600 --> 0:29:56.640
<v Speaker 3>Large number, right.

0:29:57.080 --> 0:30:02.000
<v Speaker 2>Okay, So you asked why, Yeah, I did. In short,

0:30:03.600 --> 0:30:09.000
<v Speaker 2>we don't fully know. It's always my answer.

0:30:09.360 --> 0:30:11.800
<v Speaker 3>I'm going to cross stitch that onto a pillow for you.

0:30:12.720 --> 0:30:14.000
<v Speaker 2>I would love that pillow.

0:30:14.120 --> 0:30:16.320
<v Speaker 3>Oh my gosh.

0:30:16.440 --> 0:30:20.760
<v Speaker 2>Okay. But so the question of why are infants who

0:30:20.840 --> 0:30:23.840
<v Speaker 2>get infected more likely than adults who get infected to

0:30:23.920 --> 0:30:26.880
<v Speaker 2>go on to have a chronic infection. While we don't

0:30:26.960 --> 0:30:30.120
<v Speaker 2>fully know the answer, it likely has to do with

0:30:30.160 --> 0:30:33.520
<v Speaker 2>a few different factors that relate to the various phases

0:30:33.680 --> 0:30:38.520
<v Speaker 2>of this chronic infection. So, a chronic hepatitis B infection

0:30:38.720 --> 0:30:41.960
<v Speaker 2>which is defined just as the persistence of the virus

0:30:42.040 --> 0:30:45.160
<v Speaker 2>and like detection of these viral antigens for at least

0:30:45.360 --> 0:30:49.960
<v Speaker 2>six months in the bloodstream after that point, like after

0:30:49.960 --> 0:30:54.320
<v Speaker 2>that six months point. This isn't a static infection. It's

0:30:54.480 --> 0:30:59.040
<v Speaker 2>very dynamic and it progresses through several different phases that

0:30:59.120 --> 0:31:03.520
<v Speaker 2>can vary in their length and their severity. So the

0:31:03.560 --> 0:31:07.360
<v Speaker 2>first phase is often known as immune tolerance, and that's

0:31:07.440 --> 0:31:11.200
<v Speaker 2>essentially when our body doesn't really do much about this infection.

0:31:11.760 --> 0:31:14.560
<v Speaker 2>The virus is there, and one thing that it tends

0:31:14.600 --> 0:31:18.120
<v Speaker 2>to do is integrate into our genome the way that

0:31:18.720 --> 0:31:20.440
<v Speaker 2>do you remember the other virus that does that er

0:31:20.520 --> 0:31:26.120
<v Speaker 2>in HPV HPV That's right, And as our cells replicate,

0:31:26.240 --> 0:31:29.920
<v Speaker 2>so does this virus. But in the immune tolerance phase,

0:31:30.000 --> 0:31:33.080
<v Speaker 2>it doesn't cause much in the way of damage. Then

0:31:33.120 --> 0:31:36.400
<v Speaker 2>there is the immune active phase, and in some papers

0:31:36.440 --> 0:31:39.440
<v Speaker 2>they call this the immune clearance phase. And this is

0:31:39.480 --> 0:31:43.560
<v Speaker 2>really the meat of chronic hepatitis B infection. This is

0:31:43.560 --> 0:31:47.760
<v Speaker 2>when our bodies are recognizing this virus, we are mounting

0:31:47.840 --> 0:31:52.480
<v Speaker 2>an immune response to it, and therefore we ourselves are

0:31:52.520 --> 0:31:55.720
<v Speaker 2>causing a lot of inflammation and damage to our own

0:31:55.760 --> 0:32:00.320
<v Speaker 2>liver cells. It's not the virus itself, Okay, Yeah, this

0:32:00.440 --> 0:32:03.400
<v Speaker 2>is the phase where people are more likely to be symptomatic,

0:32:03.560 --> 0:32:07.640
<v Speaker 2>like maybe have jaundice. But this is the phase where

0:32:07.680 --> 0:32:12.320
<v Speaker 2>that inflammation is causing fibrosis, which is damage to the

0:32:12.360 --> 0:32:16.360
<v Speaker 2>liver due to that inflammation. That fibrosis can eventually lead

0:32:16.400 --> 0:32:21.400
<v Speaker 2>to scarring or permanent damage cirrhosis, and that can ultimately

0:32:21.480 --> 0:32:25.240
<v Speaker 2>lead to liver cancer. And so this is the phase,

0:32:25.280 --> 0:32:28.080
<v Speaker 2>the immune active phase that the longer that somebody is

0:32:28.120 --> 0:32:31.800
<v Speaker 2>in this phase their immune system fighting the infection, the

0:32:31.840 --> 0:32:35.360
<v Speaker 2>greater their risk of cancer. Okay, but there is another

0:32:35.400 --> 0:32:39.040
<v Speaker 2>phase just get more complicated, and that's a so called

0:32:39.160 --> 0:32:42.720
<v Speaker 2>inactive phase, wherein the virus is still there and we've

0:32:42.800 --> 0:32:46.320
<v Speaker 2>maybe made some antibodies against that virus, so we're kind

0:32:46.320 --> 0:32:49.760
<v Speaker 2>of at a standstill. But at any point, people could

0:32:49.840 --> 0:32:53.280
<v Speaker 2>still revert back to a more immune active infection, like

0:32:53.600 --> 0:32:57.360
<v Speaker 2>say if they became immuno compromised for some reason and

0:32:57.440 --> 0:33:00.400
<v Speaker 2>therefore the virus is still there and still posing risk

0:33:00.480 --> 0:33:01.480
<v Speaker 2>of cancer development.

0:33:02.080 --> 0:33:03.920
<v Speaker 4>Gotcha that makes sense.

0:33:04.480 --> 0:33:06.400
<v Speaker 2>Yeah, So I know that that was a lot and

0:33:06.440 --> 0:33:09.120
<v Speaker 2>it was really just a drive by. The immunology of

0:33:09.160 --> 0:33:12.600
<v Speaker 2>HEPBIE infection is a lot more complicated. There's a lot

0:33:12.600 --> 0:33:15.200
<v Speaker 2>more detail. But one of the things that's different among

0:33:15.280 --> 0:33:19.160
<v Speaker 2>adults who get infected versus infants is that infants tend

0:33:19.160 --> 0:33:24.040
<v Speaker 2>to have a very long immune tolerant phase, whereas adults

0:33:24.160 --> 0:33:27.840
<v Speaker 2>who have chronic hepatitis B, that is, they get infected

0:33:27.880 --> 0:33:31.800
<v Speaker 2>and aren't able to clear that infection right away, they

0:33:31.840 --> 0:33:34.920
<v Speaker 2>tend to not really have an immune tolerant phase, but

0:33:35.040 --> 0:33:42.600
<v Speaker 2>rather progress directly to that active inflammatory chronic hepatitis infection. Right, Okay,

0:33:42.720 --> 0:33:45.440
<v Speaker 2>So that's a really big difference. And it's thought that

0:33:45.840 --> 0:33:51.600
<v Speaker 2>during pregnancy, viral particles or maternal antibodies or both are

0:33:51.640 --> 0:33:54.520
<v Speaker 2>passing through to the fetus, and then when that infant

0:33:54.600 --> 0:33:57.520
<v Speaker 2>is born and exposed to hepatitis B, while they're not

0:33:57.680 --> 0:34:01.560
<v Speaker 2>able to fight off that virus entire the way most

0:34:01.640 --> 0:34:06.080
<v Speaker 2>adults who are exposed can, they instead establish this relationship

0:34:06.120 --> 0:34:09.800
<v Speaker 2>of tolerance that lends itself more easily to a chronic infection.

0:34:10.680 --> 0:34:14.560
<v Speaker 3>Oh right, okay, so it's kind of like getting to

0:34:14.640 --> 0:34:17.080
<v Speaker 3>know you and like, all right, I guess we'll just

0:34:17.320 --> 0:34:19.920
<v Speaker 3>tolerate you know each other for a while.

0:34:19.920 --> 0:34:23.680
<v Speaker 2>Right, but then eventually progress to the other phases of disease.

0:34:24.120 --> 0:34:26.560
<v Speaker 4>Right, Okay, interesting.

0:34:26.520 --> 0:34:29.560
<v Speaker 2>But that is generally hepatitis B virus.

0:34:30.600 --> 0:34:33.800
<v Speaker 3>So I have a question, h you mentioned that. Okay,

0:34:34.000 --> 0:34:36.840
<v Speaker 3>there are people who become infected and they clear the virus,

0:34:36.840 --> 0:34:37.840
<v Speaker 3>they develop antibodies.

0:34:37.880 --> 0:34:38.280
<v Speaker 2>Boom.

0:34:38.480 --> 0:34:40.560
<v Speaker 3>They're in the category that you didn't discuss the later

0:34:40.600 --> 0:34:44.919
<v Speaker 3>stages on for obvious reasons. And so these people now

0:34:45.040 --> 0:34:51.000
<v Speaker 3>have a lifetime immunity to hepatitis B virus. What about

0:34:51.040 --> 0:34:55.280
<v Speaker 3>different genotypes are is there any sort of like genotype

0:34:55.640 --> 0:34:59.239
<v Speaker 3>dependent immunity where you can be infected with one genotype

0:34:59.520 --> 0:35:02.000
<v Speaker 3>and then clear that and be exposed to another one

0:35:02.080 --> 0:35:03.120
<v Speaker 3>and not clear that?

0:35:03.600 --> 0:35:08.480
<v Speaker 2>Great question, Aaron. As far as everything that I have read,

0:35:08.920 --> 0:35:14.400
<v Speaker 2>immunity to hepatitis B is immunity to hepatitis B across genotypes.

0:35:14.600 --> 0:35:18.040
<v Speaker 2>That's great news exactly. It's really great news, Aaron, because

0:35:18.040 --> 0:35:22.080
<v Speaker 2>we in fact have a vaccine for hepatitis B. It

0:35:22.160 --> 0:35:27.640
<v Speaker 2>is a recombinant vaccine that contains only the surface antigen

0:35:28.200 --> 0:35:32.480
<v Speaker 2>of hepatitis B, and that is what we make antibodies too.

0:35:32.920 --> 0:35:37.719
<v Speaker 3>Have a follow up question, Okay, if someone is chronically

0:35:37.760 --> 0:35:42.360
<v Speaker 3>infected with one genotype of hepatitis B, can they become

0:35:42.520 --> 0:35:45.360
<v Speaker 3>infected with another genotype of hepatitis B?

0:35:46.080 --> 0:35:49.319
<v Speaker 2>Not as far as I know, But do you know what?

0:35:49.360 --> 0:35:51.120
<v Speaker 2>They can become infected.

0:35:50.719 --> 0:35:52.200
<v Speaker 4>With hepatitis D.

0:35:52.760 --> 0:35:56.720
<v Speaker 2>Hepatitis D. Thanks for the little intro there.

0:35:57.600 --> 0:35:58.800
<v Speaker 4>You're welcome. You're welcome.

0:35:59.000 --> 0:36:03.000
<v Speaker 2>I want to just very we briefly mention hepatitis D

0:36:03.120 --> 0:36:05.239
<v Speaker 2>because I don't think that we would ever do a

0:36:05.280 --> 0:36:07.480
<v Speaker 2>full episode on it. I don't know, maybe I'm wrong,

0:36:08.440 --> 0:36:14.239
<v Speaker 2>but delta hepatitis virus or hepatitis delta HEPD, it's a

0:36:14.320 --> 0:36:19.840
<v Speaker 2>fascinating virus. This virus belongs to its entire own viral

0:36:19.920 --> 0:36:23.680
<v Speaker 2>genus that doesn't have an actual family that it falls within.

0:36:24.160 --> 0:36:27.120
<v Speaker 2>And some people say it's not even really a virus,

0:36:27.200 --> 0:36:31.080
<v Speaker 2>it's like something else entirely. It's a subviral agent.

0:36:32.719 --> 0:36:36.440
<v Speaker 4>Whoa what it's like a virus of a virus.

0:36:36.520 --> 0:36:43.560
<v Speaker 2>It's kind of so. Hepatitis D has an RNA genome,

0:36:44.200 --> 0:36:48.080
<v Speaker 2>and it can replicate on its own inside of our

0:36:48.160 --> 0:36:50.960
<v Speaker 2>cells and when it infects us, and it does infect

0:36:51.000 --> 0:36:56.440
<v Speaker 2>our liver cells, but it can't actually infect our cells

0:36:56.719 --> 0:37:01.959
<v Speaker 2>by itself. It relies on the surface pines of hepatitis

0:37:02.120 --> 0:37:06.479
<v Speaker 2>B virus in order to get into our cells and

0:37:07.040 --> 0:37:11.120
<v Speaker 2>in order to be released from our cells. So hepatitis

0:37:11.200 --> 0:37:14.439
<v Speaker 2>D is a virus that can only infect someone who

0:37:14.560 --> 0:37:18.560
<v Speaker 2>has a chronic or acute hepatitis B infection.

0:37:20.600 --> 0:37:22.960
<v Speaker 3>I'm really regretting right now not reading more about the

0:37:23.000 --> 0:37:27.359
<v Speaker 3>evolutionary origins of hepatitis D because.

0:37:27.520 --> 0:37:31.640
<v Speaker 2>On Earth, maybe it does deserve its whole own episode. Yeah,

0:37:32.440 --> 0:37:34.719
<v Speaker 2>that's that's literally all I have to say about it.

0:37:34.840 --> 0:37:37.080
<v Speaker 2>But it is very very interesting.

0:37:38.000 --> 0:37:42.200
<v Speaker 3>Okay, So what about besides the vaccine? What about treatments?

0:37:42.239 --> 0:37:45.520
<v Speaker 3>Are there anti viral treatments for hepatitis B virus or

0:37:45.719 --> 0:37:47.680
<v Speaker 3>maybe B and hept combined.

0:37:48.000 --> 0:37:52.000
<v Speaker 2>Yes, for hepatitis B there are. So there's a number

0:37:52.080 --> 0:37:56.160
<v Speaker 2>of different treatments that we have. Actually none of them

0:37:56.280 --> 0:37:59.719
<v Speaker 2>can cure hepatitis B. They're all used to sort of

0:37:59.760 --> 0:38:03.040
<v Speaker 2>man and to try and reduce the rate of inflammation

0:38:03.200 --> 0:38:08.040
<v Speaker 2>and complications. But pigilated interferon, which I think we talked

0:38:08.040 --> 0:38:12.839
<v Speaker 2>about in our hepsy episode. Possibly, but that's basically like

0:38:12.960 --> 0:38:16.600
<v Speaker 2>an immune modulator you can think of it as that

0:38:17.080 --> 0:38:19.600
<v Speaker 2>can be used and has been used to treat hepatitis B.

0:38:19.960 --> 0:38:23.840
<v Speaker 2>But there are also a number of anti virals that

0:38:24.280 --> 0:38:27.479
<v Speaker 2>in many cases are used to treat HIV or we're

0:38:27.680 --> 0:38:30.000
<v Speaker 2>used to treat HIV and are now used to treat

0:38:30.360 --> 0:38:34.440
<v Speaker 2>he B. So yes, there are Again, none of them

0:38:34.520 --> 0:38:36.960
<v Speaker 2>actually clear the infection, but they all just sort of

0:38:36.960 --> 0:38:40.840
<v Speaker 2>help to manage it. Okay, And what's really important about

0:38:40.880 --> 0:38:44.760
<v Speaker 2>all of these is that because all of those different

0:38:44.760 --> 0:38:50.560
<v Speaker 2>states immune tolerance, immune active, inactive, these different phases of

0:38:50.719 --> 0:38:55.360
<v Speaker 2>infection really very person to person and how severe someone's

0:38:55.360 --> 0:39:00.000
<v Speaker 2>symptoms might be, like it really varies. So just because

0:39:00.160 --> 0:39:05.719
<v Speaker 2>someone has an infection with chronic hepatitis B doesn't necessarily

0:39:05.760 --> 0:39:08.080
<v Speaker 2>mean that they have to be on treatment if they're

0:39:08.080 --> 0:39:10.759
<v Speaker 2>in a phase that isn't directly causing damage. Does that?

0:39:10.800 --> 0:39:12.960
<v Speaker 4>Okay? Yeah, that's interesting.

0:39:12.640 --> 0:39:15.600
<v Speaker 2>At least as of now, because the treatments that we

0:39:15.680 --> 0:39:17.640
<v Speaker 2>do have are not without side effects, and in a

0:39:17.640 --> 0:39:19.680
<v Speaker 2>lot of cases they have quite a lot of side effects,

0:39:21.000 --> 0:39:24.040
<v Speaker 2>so it requires a lot of careful monitoring and everything,

0:39:24.080 --> 0:39:26.640
<v Speaker 2>which makes it a lot harder to do. Quite honestly,

0:39:27.320 --> 0:39:30.160
<v Speaker 2>there's so much here about this virus that I know,

0:39:31.400 --> 0:39:35.600
<v Speaker 2>so speaking of so much about this virus arin like,

0:39:35.960 --> 0:39:37.960
<v Speaker 2>what where did it come from? What the heck?

0:39:39.360 --> 0:39:41.840
<v Speaker 3>I will do my best to answer those questions, But

0:39:41.960 --> 0:40:19.239
<v Speaker 3>let's take a quick break first, all right, the story

0:40:19.360 --> 0:40:23.080
<v Speaker 3>of hepatitis B. I feel like in the last couple

0:40:23.120 --> 0:40:27.040
<v Speaker 3>of episodes, I've maybe deviated a bit from the normal

0:40:27.200 --> 0:40:31.399
<v Speaker 3>history overview that I usually give. But don't worry, I'm

0:40:31.440 --> 0:40:35.600
<v Speaker 3>going back to my roots for this one. I'm going

0:40:35.680 --> 0:40:38.320
<v Speaker 3>to start with a bit of evolutionary history, mix in

0:40:38.400 --> 0:40:42.920
<v Speaker 3>some early accounts of infectious hepatitis, then the fascinating story

0:40:42.960 --> 0:40:46.479
<v Speaker 3>of its identification, and then finally getting us to where

0:40:46.480 --> 0:40:47.240
<v Speaker 3>we are today.

0:40:48.000 --> 0:40:51.600
<v Speaker 2>The usual, the usually, I love it, but usual.

0:40:51.320 --> 0:40:55.279
<v Speaker 3>Doesn't mean boring or straightforward, especially in the case of

0:40:55.400 --> 0:41:00.920
<v Speaker 3>hepatitis B. So beginning at the beginning, where does the

0:41:00.960 --> 0:41:05.120
<v Speaker 3>hepatitis B virus come from? It turns out that the

0:41:05.160 --> 0:41:08.600
<v Speaker 3>answer to that question has been a moving target for

0:41:08.719 --> 0:41:13.399
<v Speaker 3>a number of years, with new hypotheses introduced or old

0:41:13.480 --> 0:41:17.959
<v Speaker 3>hypotheses overturned or tweaked to fit new findings. As more

0:41:17.960 --> 0:41:21.359
<v Speaker 3>about the evolutionary history of this virus has come to light,

0:41:22.400 --> 0:41:25.640
<v Speaker 3>and this should come as no surprise really, considering how

0:41:25.760 --> 0:41:29.680
<v Speaker 3>widespread this virus is, how many genotypes there seem to be,

0:41:30.440 --> 0:41:35.279
<v Speaker 3>how the virus can undergo recombination, the confusion about its

0:41:35.480 --> 0:41:39.600
<v Speaker 3>partially double stranded DNA, and how we don't really know

0:41:39.760 --> 0:41:41.520
<v Speaker 3>exactly maybe the rate.

0:41:41.400 --> 0:41:42.840
<v Speaker 4>Of evolution or mutation.

0:41:44.160 --> 0:41:46.480
<v Speaker 3>There's been a lot of work on this I was

0:41:46.640 --> 0:41:50.600
<v Speaker 3>happily surprised to find, especially recently, and so I'm going

0:41:50.680 --> 0:41:52.919
<v Speaker 3>to try to bring us up to speed on what

0:41:53.000 --> 0:41:57.000
<v Speaker 3>the current consensus is relying mostly on two papers that

0:41:57.080 --> 0:42:00.560
<v Speaker 3>came out in twenty twenty one about the origins evolution

0:42:00.760 --> 0:42:05.040
<v Speaker 3>of the hepatitis B virus, one by Lochernini at all

0:42:05.160 --> 0:42:08.839
<v Speaker 3>and the other Bycolture at All. Like you said, Erin,

0:42:09.040 --> 0:42:13.560
<v Speaker 3>the hepatitis B virus belongs to the Hepadinaviidae family, and

0:42:13.800 --> 0:42:17.359
<v Speaker 3>in the years after the hepatitis B virus was first identified,

0:42:17.840 --> 0:42:23.759
<v Speaker 3>researchers found viruses belonging to that family that infected birds, fish, reptiles,

0:42:23.800 --> 0:42:27.600
<v Speaker 3>and amphibians, other mammals, non human primates.

0:42:27.040 --> 0:42:27.520
<v Speaker 4>Et cetera.

0:42:28.320 --> 0:42:31.600
<v Speaker 3>Basically, this is a lot bigger and a lot older

0:42:31.640 --> 0:42:35.080
<v Speaker 3>of a virus family than we thought with there. And

0:42:35.120 --> 0:42:38.480
<v Speaker 3>there are some estimates that it originated around eighty two

0:42:38.560 --> 0:42:39.479
<v Speaker 3>million years ago.

0:42:39.840 --> 0:42:42.040
<v Speaker 4>WHOA, So, like this thing.

0:42:42.040 --> 0:42:48.480
<v Speaker 3>Was infecting birds essentially, Yeah, back when birds and dinosaurs

0:42:48.480 --> 0:42:52.960
<v Speaker 3>were the same thing. Yeah, I hope that that's probably

0:42:52.960 --> 0:42:56.160
<v Speaker 3>not accurate, but you know what I mean, eighty two

0:42:56.160 --> 0:42:59.000
<v Speaker 3>million years let's stick with that. Yeah, So from eighty

0:42:59.040 --> 0:43:02.200
<v Speaker 3>two million years years ago, how did it get into

0:43:02.440 --> 0:43:06.319
<v Speaker 3>modern humans? And on that there seems to be some

0:43:06.480 --> 0:43:11.040
<v Speaker 3>debate surprise surprise for a long time, it was thought

0:43:11.120 --> 0:43:15.600
<v Speaker 3>that hepatitis B virus originated in Africa, or for a

0:43:15.680 --> 0:43:19.040
<v Speaker 3>while it was thought maybe the Americas, and then it

0:43:19.160 --> 0:43:23.160
<v Speaker 3>spilled over into humans, possibly from like a non human primate,

0:43:23.480 --> 0:43:27.360
<v Speaker 3>and then dispersed. Maybe it was dispersing out of Africa

0:43:27.560 --> 0:43:33.000
<v Speaker 3>following prehistoric patterns of human migrations. But more recently that

0:43:33.120 --> 0:43:37.280
<v Speaker 3>assumption has been questioned. So one of the studies published

0:43:37.280 --> 0:43:41.319
<v Speaker 3>in twenty twenty one used hepatitis B virus detected in

0:43:41.440 --> 0:43:45.840
<v Speaker 3>skeletal remains of one hundred and thirty seven individuals found

0:43:45.920 --> 0:43:50.080
<v Speaker 3>in Eurasia and the Americas and dating between ten thousand,

0:43:50.280 --> 0:43:53.840
<v Speaker 3>five hundred years ago and four hundred years ago. What

0:43:54.800 --> 0:43:58.400
<v Speaker 3>that's some old viral DNA.

0:43:58.880 --> 0:44:01.520
<v Speaker 2>I just love it when you find things like this, Aaron,

0:44:02.040 --> 0:44:02.680
<v Speaker 2>I know.

0:44:02.760 --> 0:44:06.400
<v Speaker 3>It's This paper was really interesting. It also had the

0:44:06.400 --> 0:44:09.040
<v Speaker 3>most authors of any paper I've ever seen. I think

0:44:09.040 --> 0:44:10.520
<v Speaker 3>it was one hundred and seventy something.

0:44:10.640 --> 0:44:14.480
<v Speaker 2>Oh my goodness, that's more than like the whole human

0:44:14.520 --> 0:44:15.360
<v Speaker 2>genome paper.

0:44:18.040 --> 0:44:20.040
<v Speaker 3>But I mean it makes sense because I'm assuming that

0:44:20.040 --> 0:44:23.680
<v Speaker 3>there was a lot of collaboration across many different universities

0:44:23.719 --> 0:44:28.560
<v Speaker 3>with all of these remains, skeletal remains so okay.

0:44:28.680 --> 0:44:30.359
<v Speaker 4>Anyway, So what this.

0:44:30.400 --> 0:44:34.960
<v Speaker 3>Paper, using all of these old skeletal remains with hepatitis

0:44:35.000 --> 0:44:38.600
<v Speaker 3>B virus did is that they wanted to reconstruct the

0:44:38.640 --> 0:44:43.520
<v Speaker 3>evolutionary history and dispersion of the virus. And what they

0:44:43.520 --> 0:44:46.759
<v Speaker 3>propose is that the most recent common ancestor of the

0:44:46.760 --> 0:44:51.120
<v Speaker 3>hepatitis B virus dates back to around twelve thousand to

0:44:51.200 --> 0:44:54.759
<v Speaker 3>sixteen thousand years ago, which is more recent actually than

0:44:54.920 --> 0:44:58.960
<v Speaker 3>was previously thought. And it places that most recent common

0:44:59.000 --> 0:45:03.000
<v Speaker 3>ancestor in your Asia, where over the next hundreds and

0:45:03.239 --> 0:45:07.720
<v Speaker 3>thousands of years it spread across Eurasia, into Africa, through

0:45:07.760 --> 0:45:12.879
<v Speaker 3>Europe and to the Americas. It seems like the emergence

0:45:13.000 --> 0:45:15.840
<v Speaker 3>of the hepatitis B virus and some of it spread

0:45:16.040 --> 0:45:19.800
<v Speaker 3>happened to before the Neolithic Revolution, which is when people

0:45:19.800 --> 0:45:22.759
<v Speaker 3>began settling in larger groups and farming and so on.

0:45:23.680 --> 0:45:26.200
<v Speaker 3>And if you think about it, this completely makes sense

0:45:27.200 --> 0:45:30.799
<v Speaker 3>because what are some of the transmission characteristics that hepatitis

0:45:30.840 --> 0:45:34.600
<v Speaker 3>BEE has. Right, People can be carriers. It can be

0:45:34.640 --> 0:45:37.320
<v Speaker 3>transmitted to a baby at birth. It can be spread

0:45:37.360 --> 0:45:41.680
<v Speaker 3>during sexual contact or through blood so like violent interactions

0:45:41.880 --> 0:45:45.239
<v Speaker 3>or tattooing. Even there are many different ways that this

0:45:45.400 --> 0:45:49.719
<v Speaker 3>virus can be transmitted, and the fact that there are

0:45:50.040 --> 0:45:52.680
<v Speaker 3>people who can carry it for long periods of time

0:45:53.440 --> 0:45:57.680
<v Speaker 3>means that it doesn't need this critical population size in

0:45:57.760 --> 0:46:00.000
<v Speaker 3>order to spread or persist in a pupeat.

0:46:01.719 --> 0:46:04.120
<v Speaker 2>So in that way, it's a lot like a couple of.

0:46:04.040 --> 0:46:06.880
<v Speaker 3>The other viruses that we've talked about before, like the

0:46:06.920 --> 0:46:12.200
<v Speaker 3>herpee simplex virus or chicken pox virus. But once people

0:46:12.360 --> 0:46:15.839
<v Speaker 3>began settling in larger groups around seven thousand to eight

0:46:15.840 --> 0:46:20.640
<v Speaker 3>thousand years ago, that meant, of course, more opportunities for transmission,

0:46:21.040 --> 0:46:24.360
<v Speaker 3>which led to an increase in the diversity of hepatitis

0:46:24.400 --> 0:46:29.359
<v Speaker 3>B virus strains and the emergence of multiple genotypes or lineages.

0:46:30.400 --> 0:46:31.160
<v Speaker 4>I'm not going to go.

0:46:31.080 --> 0:46:33.920
<v Speaker 3>Into a ton of detail about this, but the paper

0:46:33.960 --> 0:46:37.600
<v Speaker 3>that I keep mentioning by Kosher at all actually trace

0:46:37.719 --> 0:46:41.719
<v Speaker 3>the kind of like rise and fall of different hepatitis

0:46:41.760 --> 0:46:45.880
<v Speaker 3>B virus lineages. So one, for instance, seemed to be

0:46:45.960 --> 0:46:50.120
<v Speaker 3>the prevailing lineage in western Eurasia for like four thousand years,

0:46:50.600 --> 0:46:54.120
<v Speaker 3>but then it disappeared around thirty three hundred years ago.

0:46:54.840 --> 0:47:00.440
<v Speaker 3>It just went almost extinct. No idea why, Maybe sampling bias,

0:47:00.480 --> 0:47:03.000
<v Speaker 3>maybe a reduction in human population that kind of like

0:47:03.120 --> 0:47:06.279
<v Speaker 3>bottlenecked or eliminated it, or maybe it was like inter

0:47:06.480 --> 0:47:07.680
<v Speaker 3>genotype dynamics.

0:47:07.719 --> 0:47:10.880
<v Speaker 2>Who knows, so interesting.

0:47:10.520 --> 0:47:15.759
<v Speaker 3>Eron, I find this so fascinating, and this pattern of

0:47:15.840 --> 0:47:20.080
<v Speaker 3>genotypes going extinct and shifts in the predominant genotype, it

0:47:20.160 --> 0:47:22.480
<v Speaker 3>still happens today, and we don't know for sure, but

0:47:22.600 --> 0:47:26.160
<v Speaker 3>maybe it's partially due to the fact that some genotypes

0:47:26.200 --> 0:47:30.279
<v Speaker 3>may be associated with certain transmission routes I've seen, and

0:47:30.440 --> 0:47:33.440
<v Speaker 3>maybe some of the genotypes vary in their ability to

0:47:33.560 --> 0:47:37.279
<v Speaker 3>cause severe disease or in their ability to cause this

0:47:37.400 --> 0:47:41.560
<v Speaker 3>persistent carrier state. And so that's I think why it's

0:47:41.640 --> 0:47:45.440
<v Speaker 3>really important to understand the origins and the evolutionary history

0:47:45.520 --> 0:47:49.040
<v Speaker 3>of a virus like the hepatitis B virus. It can

0:47:49.080 --> 0:47:51.440
<v Speaker 3>tell us, in part why we see some of the

0:47:51.440 --> 0:47:55.440
<v Speaker 3>epidemiological patterns that we see today, and it might be

0:47:55.520 --> 0:47:58.600
<v Speaker 3>helpful for predicting what we could expect to see in

0:47:58.680 --> 0:48:03.279
<v Speaker 3>the future. Okay, so we have this virus that has

0:48:03.400 --> 0:48:07.480
<v Speaker 3>ancient roots and that had reached a global distribution a

0:48:07.520 --> 0:48:11.240
<v Speaker 3>long time before the present day. And I already mentioned

0:48:11.280 --> 0:48:14.840
<v Speaker 3>that evidence of hepatitis B infection has been found in

0:48:14.960 --> 0:48:18.720
<v Speaker 3>ancient human remains dating back thousands of thousands of years

0:48:19.200 --> 0:48:22.520
<v Speaker 3>as well as just a couple thousand years as well

0:48:22.560 --> 0:48:25.879
<v Speaker 3>as more recent So basically it's kind of like persisted

0:48:26.080 --> 0:48:31.879
<v Speaker 3>in human populations for all of that time. But were

0:48:31.920 --> 0:48:35.200
<v Speaker 3>the people who were around back then aware of this?

0:48:35.760 --> 0:48:36.880
<v Speaker 4>Did they have any idea?

0:48:37.320 --> 0:48:38.239
<v Speaker 2>Were they did?

0:48:38.280 --> 0:48:39.480
<v Speaker 4>They?

0:48:39.719 --> 0:48:44.680
<v Speaker 3>Well, probably in a sense. So jaundice, which can be

0:48:44.719 --> 0:48:48.160
<v Speaker 3>caused by many different things, including the hepatitis B virus,

0:48:48.360 --> 0:48:51.880
<v Speaker 3>has long been recognized and described an ancient medical text.

0:48:52.719 --> 0:48:56.320
<v Speaker 3>I'll toss in the Hippocratic texts from around four hundred

0:48:56.360 --> 0:48:59.200
<v Speaker 3>BCE because it's an episode of this podcast Will.

0:48:59.120 --> 0:48:59.520
<v Speaker 4>Kill You.

0:49:02.280 --> 0:49:06.279
<v Speaker 3>And and outbreaks of jaundice were also written about. So

0:49:06.400 --> 0:49:09.080
<v Speaker 3>one paper I read suggested that there was a description

0:49:09.200 --> 0:49:12.480
<v Speaker 3>of what was likely infectious hepatitis dating back to the

0:49:12.560 --> 0:49:17.280
<v Speaker 3>eighth century CE, and it was sometimes called campaign jaundice

0:49:17.440 --> 0:49:21.480
<v Speaker 3>because it seemed prevalent during times of war. Surprise, surprise,

0:49:22.960 --> 0:49:26.480
<v Speaker 3>But switching from talking about the evolutionary history of the

0:49:26.480 --> 0:49:30.840
<v Speaker 3>hepatitis B virus to the written human history part, it's

0:49:30.920 --> 0:49:37.680
<v Speaker 3>tricky because of the existence of other hepatitis viruses hepatiti hepatid.

0:49:39.080 --> 0:49:43.080
<v Speaker 3>We can test human remains for hepatitis B virus specifically,

0:49:43.480 --> 0:49:46.800
<v Speaker 3>but we can't always know which hepatitis virus was causing

0:49:46.840 --> 0:49:51.279
<v Speaker 3>whatever outbreak that was being described. How likely was it

0:49:51.360 --> 0:49:55.680
<v Speaker 3>that it was hepatitis B in terms of outbreaks, I

0:49:55.719 --> 0:49:59.040
<v Speaker 3>would guess actually that the hepatitis A virus which is

0:49:59.080 --> 0:50:03.640
<v Speaker 3>transmitted f may have been the culprit more often than not,

0:50:03.880 --> 0:50:08.520
<v Speaker 3>especially in crowded or unsanitary conditions like you know, war.

0:50:08.760 --> 0:50:13.880
<v Speaker 2>Yeah, and especially in any that were like acute infections.

0:50:14.560 --> 0:50:19.480
<v Speaker 3>Yes, like mm hm exactly, yeah. But it's certainly possible

0:50:19.520 --> 0:50:24.640
<v Speaker 3>that hepatitis BE and other hepatitis viruses transmitted through blood

0:50:24.840 --> 0:50:29.759
<v Speaker 3>or bodily fluids caused outbreaks, especially as the use and

0:50:29.880 --> 0:50:34.200
<v Speaker 3>reuse of needles became more popular around the middle of

0:50:34.239 --> 0:50:38.680
<v Speaker 3>the nineteenth century. So let's fast forward to then the

0:50:38.760 --> 0:50:42.640
<v Speaker 3>last decades of the eighteen hundreds, So this is like

0:50:42.880 --> 0:50:46.640
<v Speaker 3>after the development of germ theory and after the introduction

0:50:46.800 --> 0:50:52.040
<v Speaker 3>of some injectable vaccines. In eighteen eighty five, an epidemic

0:50:52.080 --> 0:50:57.719
<v Speaker 3>of jaundice followed a smallpox vaccination campaign among shipworkers in Bremen, Germany,

0:50:58.360 --> 0:51:01.480
<v Speaker 3>which led to what seems like an early indication that

0:51:01.520 --> 0:51:05.719
<v Speaker 3>hepatitis outbreaks could be caused by the reuse of needles,

0:51:05.880 --> 0:51:11.000
<v Speaker 3>or because this particular vaccine used like human serum as

0:51:11.040 --> 0:51:14.480
<v Speaker 3>a stabilizing agent through like blood products.

0:51:15.960 --> 0:51:17.520
<v Speaker 4>But the link between the.

0:51:17.480 --> 0:51:21.640
<v Speaker 3>Administration of this vaccine and the resulting hepatitis outbreak it

0:51:21.719 --> 0:51:27.360
<v Speaker 3>wasn't recognized for decades, possibly obscured by this long standing

0:51:27.400 --> 0:51:31.879
<v Speaker 3>recognition that epidemics of hepatitis or jaundice were also known

0:51:31.920 --> 0:51:35.680
<v Speaker 3>to frequently happen in overcrowded, unsanitary areas, so it was

0:51:35.719 --> 0:51:40.120
<v Speaker 3>more difficult to pinpoint the vaccine itself as the cause,

0:51:40.320 --> 0:51:42.640
<v Speaker 3>rather than like, oh, well, maybe they all went to

0:51:42.760 --> 0:51:46.959
<v Speaker 3>the same watering hole, to the same to the same

0:51:47.040 --> 0:51:49.920
<v Speaker 3>watering hole where they all got hepatitis.

0:51:50.080 --> 0:51:51.239
<v Speaker 2>Yeah.

0:51:51.440 --> 0:51:51.720
<v Speaker 4>Yeah.

0:51:52.000 --> 0:51:55.920
<v Speaker 3>But as blood transfusions increased and the practice of reusing

0:51:56.000 --> 0:51:59.880
<v Speaker 3>needles persisted, there was this growing suspicion that an in

0:52:00.000 --> 0:52:03.799
<v Speaker 3>infectious hepatitis might also be carried in the blood or

0:52:03.840 --> 0:52:09.520
<v Speaker 3>blood products. See our hepatitis c episode for more on

0:52:09.640 --> 0:52:12.720
<v Speaker 3>the history of blood transfusions and the blood typing system

0:52:13.080 --> 0:52:19.880
<v Speaker 3>and so on. The differentiation of two different hepatitises, one

0:52:20.120 --> 0:52:24.680
<v Speaker 3>called transfusion hepatitis and the other one being called infectious

0:52:24.840 --> 0:52:28.120
<v Speaker 3>or food or waterborne hepatitis. This was finally made in

0:52:28.160 --> 0:52:32.319
<v Speaker 3>the early nineteen forties. During World War Two, hundreds of

0:52:32.320 --> 0:52:36.920
<v Speaker 3>thousands of US Army personnel received the yellow fever vaccine, which,

0:52:37.360 --> 0:52:40.840
<v Speaker 3>like the eighteen eighty five smallpox vaccine, had human serum

0:52:41.000 --> 0:52:41.920
<v Speaker 3>as an ingredient.

0:52:42.719 --> 0:52:44.480
<v Speaker 4>Obviously that's no longer.

0:52:44.239 --> 0:52:50.080
<v Speaker 3>Done for safety reasons needed to maybe clarify that. But

0:52:50.200 --> 0:52:55.719
<v Speaker 3>after receiving this vaccine, fifty thousand people came down with hepatitis,

0:52:56.280 --> 0:52:59.520
<v Speaker 3>although those were just the clinically recognized cases.

0:53:00.120 --> 0:53:01.560
<v Speaker 4>Later estimates put the.

0:53:01.520 --> 0:53:05.680
<v Speaker 3>Total figure of hepatitis infections resulting from this vaccination campaign

0:53:06.400 --> 0:53:09.520
<v Speaker 3>at around three hundred and thirty thousand.

0:53:10.160 --> 0:53:14.680
<v Speaker 2>Oh dear, okay, oh gosh, oh dear, okay.

0:53:14.320 --> 0:53:15.680
<v Speaker 4>It's a lot, it's a lot.

0:53:16.200 --> 0:53:17.640
<v Speaker 2>Yeah.

0:53:17.680 --> 0:53:21.000
<v Speaker 3>And there was a British doctor named F. O. Mcallum

0:53:21.239 --> 0:53:24.359
<v Speaker 3>who had been involved in the development and administration of

0:53:24.400 --> 0:53:27.600
<v Speaker 3>this vaccine, and he hypothesized that it might have been

0:53:27.640 --> 0:53:32.200
<v Speaker 3>transmitted by reusing syringes or carried in the vaccine itself.

0:53:32.680 --> 0:53:36.160
<v Speaker 3>And he thought that this hepatitis represented a blood born infection,

0:53:36.760 --> 0:53:42.319
<v Speaker 3>separate from the previously recognized food and waterborn hepatitis. He

0:53:42.480 --> 0:53:47.080
<v Speaker 3>proposed that they be called hepatitis A and B and

0:53:47.160 --> 0:53:49.480
<v Speaker 3>that they may represent different viruses.

0:53:50.520 --> 0:53:52.120
<v Speaker 2>So this is how it begins.

0:53:52.600 --> 0:53:56.680
<v Speaker 3>This is how it begins, because at the time it

0:53:56.719 --> 0:54:00.640
<v Speaker 3>was like not known whether it was the virus or

0:54:00.680 --> 0:54:02.880
<v Speaker 3>different viruses, and so it was more in like the

0:54:03.000 --> 0:54:04.959
<v Speaker 3>clinical picture of.

0:54:04.880 --> 0:54:07.400
<v Speaker 4>It in a way. Because after this.

0:54:07.440 --> 0:54:10.640
<v Speaker 3>Designation, after this recognition that like, hey, this might be

0:54:10.719 --> 0:54:14.360
<v Speaker 3>transmitted through blood products and not just through like food

0:54:14.400 --> 0:54:19.360
<v Speaker 3>and water or whatever, other researchers began to describe differences

0:54:19.480 --> 0:54:24.520
<v Speaker 3>in the way that these two hepatida looked clinically and

0:54:24.560 --> 0:54:27.440
<v Speaker 3>to kind of keep an eye out more on the

0:54:27.480 --> 0:54:28.919
<v Speaker 3>different roots of transmission.

0:54:29.560 --> 0:54:32.520
<v Speaker 2>Once you have it more like, hey, there are two

0:54:32.520 --> 0:54:34.640
<v Speaker 2>different things here, then you start to notice more of

0:54:34.640 --> 0:54:35.320
<v Speaker 2>the differences.

0:54:35.719 --> 0:54:35.879
<v Speaker 4>Right.

0:54:35.920 --> 0:54:39.799
<v Speaker 3>Once you create those like columns, then it's then it

0:54:39.840 --> 0:54:45.319
<v Speaker 3>becomes much easier to add to the listen. But just

0:54:45.400 --> 0:54:48.759
<v Speaker 3>because people now knew that hepatitis could be transmitted by

0:54:48.800 --> 0:54:52.920
<v Speaker 3>reusing needles or via blood products, that didn't mean they

0:54:52.960 --> 0:54:56.840
<v Speaker 3>could stop it from happening. Liked I talked about in

0:54:56.880 --> 0:55:01.279
<v Speaker 3>our hepatitis see episode. Blood transfusion or blood product technology

0:55:01.880 --> 0:55:06.000
<v Speaker 3>vastly outpaced our ability to identify many blood borne pathogens,

0:55:06.400 --> 0:55:11.440
<v Speaker 3>especially viruses, which led to blood products that were unknowingly contaminated,

0:55:12.480 --> 0:55:15.200
<v Speaker 3>and often it was seen as this kind of situation

0:55:15.320 --> 0:55:18.880
<v Speaker 3>where it was like, well, we don't know whether or

0:55:18.960 --> 0:55:21.920
<v Speaker 3>not this batch of blood has hepatitis virus in it,

0:55:22.080 --> 0:55:25.799
<v Speaker 3>but you can either receive the blood and possibly get

0:55:25.800 --> 0:55:29.239
<v Speaker 3>hepatitis down the line, or not take the blood and

0:55:29.360 --> 0:55:33.240
<v Speaker 3>die of blood loss immediately. So there was like no choice.

0:55:33.480 --> 0:55:38.000
<v Speaker 3>Sometimes there was no option. That's not to say that

0:55:38.040 --> 0:55:40.480
<v Speaker 3>people weren't working on finding a way to test the

0:55:40.480 --> 0:55:44.600
<v Speaker 3>blood supply and identify what was causing the hepatitis. If anything,

0:55:44.920 --> 0:55:48.120
<v Speaker 3>it was that feeling of being powerless to protect people

0:55:48.200 --> 0:55:51.400
<v Speaker 3>from this disease that created a sense of urgency in

0:55:51.480 --> 0:55:54.960
<v Speaker 3>finding out what the hepatitis bee agent was so that

0:55:55.040 --> 0:55:59.000
<v Speaker 3>they could detect it in blood products. But despite a

0:55:59.080 --> 0:56:02.719
<v Speaker 3>ton of people work looking on this, progress kind of

0:56:03.000 --> 0:56:07.680
<v Speaker 3>stalled in the nineteen fifties and early nineteen sixties. And

0:56:07.760 --> 0:56:11.080
<v Speaker 3>I think it stalled partially because this was a time

0:56:11.120 --> 0:56:14.760
<v Speaker 3>when virology was kind of in its infancy as a field,

0:56:15.200 --> 0:56:18.279
<v Speaker 3>and the technology that would allow for genetic testing or

0:56:18.280 --> 0:56:20.320
<v Speaker 3>sequencing was still decades away.

0:56:20.920 --> 0:56:24.960
<v Speaker 2>I'm sorry, I just I had I don't know how

0:56:25.080 --> 0:56:30.000
<v Speaker 2>I didn't know that it was so recent I know,

0:56:30.520 --> 0:56:35.480
<v Speaker 2>like nineteen fifties, nineteen sixties, that's not a long time ago.

0:56:36.160 --> 0:56:36.839
<v Speaker 4>It is.

0:56:37.480 --> 0:56:43.400
<v Speaker 3>All of the hepatitis viruses are like have very recent

0:56:44.000 --> 0:56:48.920
<v Speaker 3>identification dates, but have been recognized for decades before that.

0:56:49.000 --> 0:56:52.800
<v Speaker 3>And it's just sort of this like constantly unfolding tragedy

0:56:52.840 --> 0:56:55.200
<v Speaker 3>where you're just like you see it, and you're like

0:56:55.360 --> 0:56:57.359
<v Speaker 3>and they know, Like the people who were there at

0:56:57.360 --> 0:56:59.920
<v Speaker 3>the time are like, I can't, Like, this might have

0:57:00.080 --> 0:57:03.240
<v Speaker 3>hepatitis virus in it, but I can't do anything about it.

0:57:03.160 --> 0:57:06.200
<v Speaker 2>Right, But I don't but I don't know it.

0:57:06.600 --> 0:57:08.200
<v Speaker 3>I am like, I know it, but I.

0:57:08.120 --> 0:57:09.320
<v Speaker 2>Can't know it.

0:57:10.200 --> 0:57:13.560
<v Speaker 3>Mm hmm. And we can also blame the virus itself,

0:57:13.640 --> 0:57:17.840
<v Speaker 3>because this isn't to say that virology research on all fields,

0:57:17.840 --> 0:57:20.560
<v Speaker 3>on all viruses had stopped or stalled by the early

0:57:20.640 --> 0:57:24.439
<v Speaker 3>nineteen fifties or sixties, because some were easier to work

0:57:24.480 --> 0:57:27.320
<v Speaker 3>with in a lab setting than others. Yeah, and hepatitis

0:57:27.360 --> 0:57:30.760
<v Speaker 3>B virus doesn't really lend itself very well to culturing

0:57:31.080 --> 0:57:34.840
<v Speaker 3>in a lab setting, and so it was just more difficult.

0:57:34.960 --> 0:57:36.480
<v Speaker 4>And especially if you don't know even.

0:57:36.360 --> 0:57:38.360
<v Speaker 3>What you're looking for, how do you know that you're

0:57:38.400 --> 0:57:39.240
<v Speaker 3>on the right track?

0:57:39.280 --> 0:57:39.560
<v Speaker 1>At all.

0:57:40.080 --> 0:57:43.320
<v Speaker 2>Yeah, and it's a weird virus. We already said that, Yeah,

0:57:43.400 --> 0:57:46.600
<v Speaker 2>it's a weird, very weird. And at the time it

0:57:46.680 --> 0:57:50.560
<v Speaker 2>wasn't People were using the term virus, but it wasn't

0:57:50.600 --> 0:57:54.960
<v Speaker 2>known for sure whether it was a virus or something else.

0:57:55.560 --> 0:57:58.440
<v Speaker 2>It was like known to be a virus in concept,

0:57:58.600 --> 0:58:02.240
<v Speaker 2>but without physical proof. But by the end of the

0:58:02.320 --> 0:58:07.160
<v Speaker 2>nineteen sixties that would change, and the team that led

0:58:07.160 --> 0:58:11.520
<v Speaker 2>to the breakthrough identification of the hepatitis B virus would

0:58:11.600 --> 0:58:15.240
<v Speaker 2>not have been on anyone's short or even long list

0:58:15.320 --> 0:58:17.760
<v Speaker 2>of people that were likely to have done the job.

0:58:18.600 --> 0:58:19.600
<v Speaker 2>Why who was it?

0:58:21.040 --> 0:58:25.520
<v Speaker 3>Okay, I'll get there, But before we get into the

0:58:25.800 --> 0:58:29.400
<v Speaker 3>unlikely story of the discovery of the HEPB virus, I

0:58:29.440 --> 0:58:33.040
<v Speaker 3>want to quickly mention the Willowbrook State School hepatitis studies,

0:58:33.800 --> 0:58:37.560
<v Speaker 3>which were these unethical experiments that are sometimes referred to

0:58:37.680 --> 0:58:39.600
<v Speaker 3>as the pediatric Tuskegee.

0:58:40.120 --> 0:58:40.600
<v Speaker 2>Oh dear.

0:58:41.320 --> 0:58:41.640
<v Speaker 4>Yeah.

0:58:42.040 --> 0:58:45.000
<v Speaker 3>I'm going to be brief because these studies are mostly

0:58:45.000 --> 0:58:48.440
<v Speaker 3>about hepatitis A, and so when we do a HEPA episode,

0:58:48.600 --> 0:58:51.120
<v Speaker 3>I'll go into more depth on them. But I wanted

0:58:51.160 --> 0:58:53.760
<v Speaker 3>to bring them up here because these studies mark one

0:58:53.800 --> 0:58:56.400
<v Speaker 3>of the major points in the history of medical ethics,

0:58:56.800 --> 0:58:59.880
<v Speaker 3>and also hepatitis B was a part of these studies.

0:59:00.760 --> 0:59:04.520
<v Speaker 3>So Willowbrook State School was a state funded institution established

0:59:04.560 --> 0:59:07.760
<v Speaker 3>in nineteen forty seven on Staten Island, New York, for

0:59:08.040 --> 0:59:11.320
<v Speaker 3>children who were intellectually or developmentally disabled.

0:59:12.120 --> 0:59:15.120
<v Speaker 2>I hate this already, erin, I know, I know, I know.

0:59:16.000 --> 0:59:19.960
<v Speaker 3>In nineteen fifty eight, infectious disease physician doctor Saul Krugman

0:59:20.160 --> 0:59:23.360
<v Speaker 3>from New York University in Bellevue Hospital, he was asked

0:59:23.360 --> 0:59:26.280
<v Speaker 3>to join Willowbrook to help figure out why there were

0:59:26.360 --> 0:59:29.720
<v Speaker 3>such high rates of hepatitis among the children there, with

0:59:29.800 --> 0:59:32.760
<v Speaker 3>something like thirty to fifty percent admitted there would end

0:59:32.800 --> 0:59:36.600
<v Speaker 3>up getting hepatitis, and they also asked him to help

0:59:36.640 --> 0:59:39.680
<v Speaker 3>bring those rates down, and so he agreed and set

0:59:39.720 --> 0:59:42.320
<v Speaker 3>out to not only bring down the rates of hepatitis,

0:59:42.720 --> 0:59:47.120
<v Speaker 3>but also to quote describe the circumstances under which the

0:59:47.160 --> 0:59:51.640
<v Speaker 3>disease occurred and the effect of gamma globulin in reducing

0:59:51.720 --> 0:59:56.480
<v Speaker 3>its occurrence, and an attempt to induce passive active immunity

0:59:56.520 --> 1:00:01.160
<v Speaker 3>by feeding virus to persons protected by gamma globulin, and

1:00:01.440 --> 1:00:04.760
<v Speaker 3>to describe the excretion of virus during the incubation period

1:00:04.800 --> 1:00:08.320
<v Speaker 3>of the disease. Dear your face tells me you've picked

1:00:08.400 --> 1:00:13.000
<v Speaker 3>up on some of the yeah problems with these studies

1:00:13.760 --> 1:00:19.440
<v Speaker 3>intentionally infecting children. So Krugman justified the research by saying

1:00:19.520 --> 1:00:22.720
<v Speaker 3>that the children would inevitably get hepatitis anyway because it

1:00:22.760 --> 1:00:25.479
<v Speaker 3>was so prevalent in the school, and that this way,

1:00:25.520 --> 1:00:28.720
<v Speaker 3>with his experiments, a vaccine could be developed and tested.

1:00:29.800 --> 1:00:33.280
<v Speaker 3>Parental consent was obtained, but it's not clear the extent

1:00:33.320 --> 1:00:35.680
<v Speaker 3>to which parents were told of the risks to their

1:00:35.760 --> 1:00:40.120
<v Speaker 3>children and what exactly was involved. By his own estimation,

1:00:40.520 --> 1:00:45.480
<v Speaker 3>Krugman's studies reduced the incidence of hepatitis by eighty five percent. Again,

1:00:45.560 --> 1:00:50.120
<v Speaker 3>it's not entirely clear which hepatitis, but his study did

1:00:50.160 --> 1:00:53.720
<v Speaker 3>demonstrate that there were two different types of hepatitis transmitted

1:00:53.760 --> 1:00:56.160
<v Speaker 3>in different ways, which like I said, was already kind

1:00:56.160 --> 1:00:59.480
<v Speaker 3>of known, and also tested a prototype of a HEPB

1:00:59.680 --> 1:01:05.000
<v Speaker 3>vaccine which did seem to be somewhat effective. The legacy

1:01:05.040 --> 1:01:08.640
<v Speaker 3>of the Wiliberg hepatitis studies is that the resulting outrage

1:01:08.800 --> 1:01:12.760
<v Speaker 3>led to very strict regulations placed on including children in

1:01:12.800 --> 1:01:17.320
<v Speaker 3>clinical trials and medical studies, and a more revamping of

1:01:17.320 --> 1:01:21.600
<v Speaker 3>what could be considered medical consent. There's a lot more,

1:01:21.880 --> 1:01:24.640
<v Speaker 3>of course, like I said, to these studies and their

1:01:24.680 --> 1:01:27.200
<v Speaker 3>place in the history of medical ethics. And so if

1:01:27.240 --> 1:01:29.720
<v Speaker 3>you're interested in learning more and don't want to wait

1:01:29.760 --> 1:01:33.960
<v Speaker 3>for our Hepatitis A episode, I will list some sources

1:01:34.440 --> 1:01:38.000
<v Speaker 3>for this on our website. And there's also a paper

1:01:38.680 --> 1:01:42.600
<v Speaker 3>that Krugman wrote and published in nineteen eighty six in

1:01:42.640 --> 1:01:45.280
<v Speaker 3>which he defends himself in the research. So that's kind

1:01:45.320 --> 1:01:49.640
<v Speaker 3>of an interesting read. There's like a lot of discussion

1:01:49.680 --> 1:01:52.480
<v Speaker 3>about this, and I didn't do it justice, so let

1:01:52.560 --> 1:01:53.120
<v Speaker 3>me just say that.

1:01:54.280 --> 1:01:54.720
<v Speaker 2>Wow.

1:01:55.800 --> 1:02:02.360
<v Speaker 3>Yeah, okay, okay, back to strictly hepatitis B. So, by

1:02:02.360 --> 1:02:06.160
<v Speaker 3>the nineteen sixties, the hepatitis B virus had still not

1:02:06.240 --> 1:02:10.120
<v Speaker 3>been identified, despite the fact that tons of people were

1:02:10.160 --> 1:02:14.120
<v Speaker 3>working on this problem. And when it was finally discovered,

1:02:14.160 --> 1:02:17.880
<v Speaker 3>it wasn't by one of those researchers who had dedicated

1:02:17.920 --> 1:02:21.760
<v Speaker 3>their lives to hepatitis, but by a team who had

1:02:21.760 --> 1:02:25.640
<v Speaker 3>not even been looking for hepatitis B or any other virus.

1:02:27.360 --> 1:02:28.360
<v Speaker 2>What were they looking for?

1:02:31.440 --> 1:02:34.280
<v Speaker 3>I feel like this story is such a good example

1:02:34.720 --> 1:02:38.920
<v Speaker 3>of how science like rarely proceeds in an orderly fashion.

1:02:39.040 --> 1:02:40.640
<v Speaker 4>It's not a to B two C.

1:02:42.720 --> 1:02:46.480
<v Speaker 3>It's especially because B happens to be the first hepatitis

1:02:46.520 --> 1:02:47.280
<v Speaker 3>virus discovered.

1:02:47.480 --> 1:02:49.520
<v Speaker 2>Yeah, Okay, I saw that on a timeline and I

1:02:49.560 --> 1:02:51.240
<v Speaker 2>was like, well, well we'll hold on, hold on, hold on.

1:02:51.360 --> 1:02:53.000
<v Speaker 4>I don't know. It was like, why is it called B?

1:02:53.160 --> 1:02:55.360
<v Speaker 2>Then yeah, it doesn't make any sense.

1:02:57.760 --> 1:02:59.760
<v Speaker 3>Yep, everything's just arbitrary.

1:03:00.200 --> 1:03:01.040
<v Speaker 2>Cool cool, cool, yep.

1:03:02.480 --> 1:03:05.760
<v Speaker 3>But yeah, it's like we often tell, like I'm including

1:03:05.800 --> 1:03:09.240
<v Speaker 3>myself in that these stories of scientific discovery in a

1:03:09.360 --> 1:03:13.360
<v Speaker 3>very linear way, in a very like here's this nice little,

1:03:13.400 --> 1:03:18.520
<v Speaker 3>pretty narrative packaged, and that neat narrative does serve a

1:03:18.560 --> 1:03:21.400
<v Speaker 3>purpose because it kind of is like, well, let's find

1:03:21.440 --> 1:03:24.400
<v Speaker 3>the important things, let's find the compelling things. Yeah, but

1:03:25.360 --> 1:03:29.400
<v Speaker 3>that's not the way things happen. It's just simply not.

1:03:29.920 --> 1:03:34.080
<v Speaker 3>And so this, I think really illustrates that sometimes you're

1:03:34.120 --> 1:03:36.560
<v Speaker 3>looking for one thing and you end up stumbling upon

1:03:36.800 --> 1:03:39.360
<v Speaker 3>something that never even crossed your mind.

1:03:40.800 --> 1:03:44.320
<v Speaker 4>So let's meet doctor Baruch Bloomberg.

1:03:44.520 --> 1:03:45.280
<v Speaker 2>Okay, Hi.

1:03:47.080 --> 1:03:51.000
<v Speaker 3>Since early in his career, Bloomberg became interested in why

1:03:51.120 --> 1:03:55.560
<v Speaker 3>some people get sick and others don't, how genetics interacts

1:03:55.560 --> 1:03:59.880
<v Speaker 3>with human behavior and the environment to lead to disease basic,

1:04:01.720 --> 1:04:06.280
<v Speaker 3>and he became interested specifically in polymorphisms. So these are

1:04:06.320 --> 1:04:10.320
<v Speaker 3>genetic traits for which there are multiple forms. So things

1:04:10.400 --> 1:04:13.080
<v Speaker 3>like tongue twisting. Can you twist your tongue?

1:04:13.400 --> 1:04:13.680
<v Speaker 2>Yes?

1:04:14.160 --> 1:04:14.760
<v Speaker 4>Can you too?

1:04:15.680 --> 1:04:15.960
<v Speaker 2>Cool?

1:04:16.640 --> 1:04:18.280
<v Speaker 4>Blood types? What blood type are you?

1:04:18.440 --> 1:04:20.920
<v Speaker 3>I'm oh positive, I'm ab positive.

1:04:21.080 --> 1:04:21.960
<v Speaker 2>I knew that about you.

1:04:22.800 --> 1:04:23.640
<v Speaker 4>I knew that about you.

1:04:24.800 --> 1:04:28.040
<v Speaker 3>So these are examples of polymorphisms, right, Like, there are

1:04:28.080 --> 1:04:31.320
<v Speaker 3>different forms of these, and there are different distributions in

1:04:31.440 --> 1:04:35.440
<v Speaker 3>human populations, and so he wanted to see whether there

1:04:35.440 --> 1:04:40.080
<v Speaker 3>were any of these polymorphisms that were associated with susceptibility

1:04:40.120 --> 1:04:43.680
<v Speaker 3>to certain diseases. So kind of like asking the question

1:04:44.240 --> 1:04:47.280
<v Speaker 3>do people with type A blood have a greater chance

1:04:47.360 --> 1:04:51.720
<v Speaker 3>of developing heart disease? And if they do, why, But

1:04:51.800 --> 1:04:54.480
<v Speaker 3>instead of blood types, which at this point had already

1:04:54.520 --> 1:04:58.760
<v Speaker 3>been pretty well established, Bloomberg was interested in finding new

1:04:58.920 --> 1:05:03.440
<v Speaker 3>blood plasma pro teen polymorphisms that could be associated with

1:05:03.640 --> 1:05:05.760
<v Speaker 3>variation in disease susceptibility.

1:05:05.880 --> 1:05:07.240
<v Speaker 4>So that's what he was looking for.

1:05:07.400 --> 1:05:09.919
<v Speaker 2>He wasn't even looking for virus.

1:05:09.680 --> 1:05:12.960
<v Speaker 3>No, he was looking for blood plasma protein polymorphisms.

1:05:13.280 --> 1:05:17.000
<v Speaker 2>Wow, I bet he found some proteins, all right.

1:05:17.280 --> 1:05:24.240
<v Speaker 3>He certainly did but how did he find these proteins. Yeah, well,

1:05:24.280 --> 1:05:27.880
<v Speaker 3>he began his search by collecting blood samples from people

1:05:28.000 --> 1:05:30.959
<v Speaker 3>all over the world and then testing them to see

1:05:31.000 --> 1:05:36.360
<v Speaker 3>whether certain antigens appeared and in what frequency. Basically, you

1:05:36.520 --> 1:05:40.040
<v Speaker 3>use the blood of someone who had received multiple transfusions

1:05:40.080 --> 1:05:44.040
<v Speaker 3>to find antibodies against a protein antigen that was new

1:05:44.120 --> 1:05:47.800
<v Speaker 3>to them, and then you test those antibodies against other

1:05:47.840 --> 1:05:52.080
<v Speaker 3>blood samples to see how frequently it reacts, meaning how

1:05:52.080 --> 1:05:57.440
<v Speaker 3>often that protein antigen is present. Yeah, and this might

1:05:57.520 --> 1:06:01.600
<v Speaker 3>seem like a very crude protein today in the days

1:06:01.640 --> 1:06:06.280
<v Speaker 3>of like you know, super inexpensive genomic sequencing, but back then,

1:06:06.600 --> 1:06:09.160
<v Speaker 3>these were the early early years of genetics.

1:06:09.560 --> 1:06:12.080
<v Speaker 2>I mean we still do that to do like regular

1:06:12.120 --> 1:06:15.760
<v Speaker 2>blood typing. Yeah, so it was like still very useful.

1:06:16.520 --> 1:06:19.840
<v Speaker 3>It so it is, it is super useful. But the approach,

1:06:19.920 --> 1:06:23.400
<v Speaker 3>like the technology that he used, which was Agargell diffusion,

1:06:23.840 --> 1:06:27.240
<v Speaker 3>it was basically like one of the only ones available

1:06:27.240 --> 1:06:31.760
<v Speaker 3>at the time immunology was in its infancy, and so

1:06:31.880 --> 1:06:35.040
<v Speaker 3>with this approach, Bloomberg and his team identified a new

1:06:35.080 --> 1:06:39.320
<v Speaker 3>protein that they called the AG protein AG for antigen.

1:06:40.360 --> 1:06:43.880
<v Speaker 3>This protein, which they found to have an uneven global

1:06:43.920 --> 1:06:47.920
<v Speaker 3>distribution turned out to be a serum lipoprotein, so serum

1:06:48.000 --> 1:06:51.400
<v Speaker 3>protein combined with fats that may play a role in

1:06:51.440 --> 1:06:55.280
<v Speaker 3>serum cholesterol and triglyceride levels. Maybe not a strong marker

1:06:55.320 --> 1:06:57.560
<v Speaker 3>for disease susceptibility.

1:06:57.040 --> 1:06:58.840
<v Speaker 4>But it was an encouraging finding.

1:06:59.160 --> 1:07:01.760
<v Speaker 3>It showed that their technique, even though it was, you know,

1:07:01.840 --> 1:07:05.040
<v Speaker 3>maybe a little bit kind of rough handed, could be

1:07:05.200 --> 1:07:09.320
<v Speaker 3>used to find new serum proteins. So they kept looking

1:07:10.680 --> 1:07:13.640
<v Speaker 3>for the next hunt. Bloomberg teamed up with a blood

1:07:13.640 --> 1:07:18.400
<v Speaker 3>researcher named Harvey Alter, whose name you should recognize former

1:07:18.440 --> 1:07:22.400
<v Speaker 3>hepatitis C episode. Except when I looked through my notes

1:07:22.720 --> 1:07:26.320
<v Speaker 3>for his name, I didn't mention that he was the

1:07:26.400 --> 1:07:30.280
<v Speaker 3>person who identified the hepatitis C virus. And I am

1:07:30.360 --> 1:07:36.800
<v Speaker 3>so embarrassed, Like, that's kind of a fundamental, important person

1:07:37.160 --> 1:07:38.400
<v Speaker 3>for the history of hepatitis C.

1:07:39.080 --> 1:07:41.800
<v Speaker 2>I bet you talked about a lot of important things, Karen.

1:07:42.280 --> 1:07:46.320
<v Speaker 3>I'm just I'm ashamed, you know, but I am. I'm

1:07:46.360 --> 1:07:50.040
<v Speaker 3>mentioning him here, And I also want to shout out

1:07:50.080 --> 1:07:53.120
<v Speaker 3>that in twenty twenty he was awarded the Nobel Prize

1:07:53.200 --> 1:07:55.520
<v Speaker 3>for his role in hepatitis C research.

1:07:55.800 --> 1:07:56.600
<v Speaker 4>Ohty cool?

1:07:56.880 --> 1:07:58.840
<v Speaker 2>WHOA Yeah?

1:07:59.200 --> 1:08:02.600
<v Speaker 3>So anyway, Alter, who was in the beginning of his

1:08:02.960 --> 1:08:06.080
<v Speaker 3>career in the early nineteen sixties. He was interested in

1:08:06.200 --> 1:08:11.400
<v Speaker 3>why some people developed an immune response like a fever, chills, rash, etc.

1:08:12.000 --> 1:08:17.960
<v Speaker 3>After receiving a transfusion. Yeah, interesting, sef And it took

1:08:18.000 --> 1:08:20.000
<v Speaker 3>a little bit of time, little trial and error, but

1:08:20.560 --> 1:08:25.320
<v Speaker 3>Alter in Bloomberg found another polymorphism, and this they named

1:08:25.560 --> 1:08:29.120
<v Speaker 3>Australia antigen because it was first found in the blood

1:08:29.160 --> 1:08:32.920
<v Speaker 3>serum of a First Nations person from Australia.

1:08:33.840 --> 1:08:35.040
<v Speaker 4>And we've talked about the.

1:08:35.000 --> 1:08:37.920
<v Speaker 3>Problem with place names to describe a disease loads of

1:08:37.960 --> 1:08:38.679
<v Speaker 3>times before.

1:08:39.560 --> 1:08:40.680
<v Speaker 4>However, I want to.

1:08:40.640 --> 1:08:43.920
<v Speaker 3>Point out that at the time, this Australia antigen was

1:08:44.120 --> 1:08:47.200
<v Speaker 3>just thought to be a human protein, not necessarily an

1:08:47.240 --> 1:08:51.800
<v Speaker 3>actual pathogen, which surprised spoilers it turned out to be.

1:08:52.640 --> 1:08:55.800
<v Speaker 3>But in any case, the name Australia antigen it didn't

1:08:55.840 --> 1:08:58.880
<v Speaker 3>stick around for very long because it was soon shown

1:08:59.080 --> 1:09:03.400
<v Speaker 3>that the Australia antigen was actually the hepatitis B virus.

1:09:04.280 --> 1:09:05.400
<v Speaker 2>I love this story.

1:09:05.720 --> 1:09:10.280
<v Speaker 3>I know it's I just think it's so amazing. It's like,

1:09:11.040 --> 1:09:13.800
<v Speaker 3>I don't know, it's just such a fun story. So

1:09:13.880 --> 1:09:18.040
<v Speaker 3>how did they make this connection? Well, first, after finding

1:09:18.080 --> 1:09:21.200
<v Speaker 3>this new protein, they decided to look at its geographic

1:09:21.240 --> 1:09:24.120
<v Speaker 3>patterns of prevalence, just like they had for their earlier

1:09:24.320 --> 1:09:27.920
<v Speaker 3>AGG protein, which you know, was it more common in

1:09:27.920 --> 1:09:32.280
<v Speaker 3>some areas or in some populations than others, and they

1:09:32.320 --> 1:09:36.320
<v Speaker 3>did find variation in the global distribution. They found that

1:09:36.520 --> 1:09:39.559
<v Speaker 3>the Australia antigen seemed to be somewhat rare in the

1:09:39.680 --> 1:09:42.360
<v Speaker 3>US blood samples that they had, but it was a

1:09:42.360 --> 1:09:45.040
<v Speaker 3>little bit more common in parts of Asia, in the

1:09:45.040 --> 1:09:49.559
<v Speaker 3>Pacific Africa, and Eastern and southern Europe. They also showed

1:09:49.560 --> 1:09:53.120
<v Speaker 3>that the antigen seemed to cluster in families, which at

1:09:53.160 --> 1:09:57.920
<v Speaker 3>first glance suggested that it was an inherited tree, but

1:09:58.720 --> 1:10:02.479
<v Speaker 3>as more data came in, that assumption kind of broke down.

1:10:03.760 --> 1:10:06.120
<v Speaker 4>Yeah, uh huh.

1:10:06.280 --> 1:10:09.479
<v Speaker 3>Bloomberg and his team began getting suspicious that it might

1:10:09.680 --> 1:10:13.120
<v Speaker 3>not be a human protein after all, but rather an

1:10:13.120 --> 1:10:17.519
<v Speaker 3>infectious agent, one that was possibly bloodborn, as they had

1:10:17.520 --> 1:10:20.679
<v Speaker 3>found it in several people who had at first tested

1:10:20.720 --> 1:10:24.800
<v Speaker 3>negative for the antigen but later tested positive shortly after

1:10:24.840 --> 1:10:30.200
<v Speaker 3>receiving a blood transfusion. Oh no, And then the connection

1:10:30.240 --> 1:10:33.559
<v Speaker 3>to hepatitis B fell into place when they began to

1:10:33.640 --> 1:10:36.519
<v Speaker 3>find the antigen at high rates and people who had

1:10:36.560 --> 1:10:43.559
<v Speaker 3>hepatitis okay, especially those with a history of transfusion. By

1:10:43.640 --> 1:10:47.120
<v Speaker 3>nineteen sixty five or so, they had become convinced that

1:10:47.160 --> 1:10:50.439
<v Speaker 3>they had finally found the long sought after hepatitis B

1:10:50.600 --> 1:10:54.719
<v Speaker 3>virus almost by accident, I mean truly by accident, really,

1:10:56.240 --> 1:10:58.840
<v Speaker 3>and they sent off a couple of papers to be published.

1:11:00.080 --> 1:11:05.360
<v Speaker 3>One was outright rejected, with a reviewer commenting that there

1:11:05.400 --> 1:11:09.559
<v Speaker 3>simply wasn't enough evidence in support of their hypothesis. And

1:11:09.720 --> 1:11:12.679
<v Speaker 3>now we look back on this and go, that's absurd.

1:11:13.080 --> 1:11:17.600
<v Speaker 3>How could this monumental finding be rejected? But if you

1:11:17.720 --> 1:11:21.280
<v Speaker 3>consider this in the larger context of the time, it

1:11:21.400 --> 1:11:23.679
<v Speaker 3>does seem like it was kind of like a boy

1:11:23.680 --> 1:11:27.960
<v Speaker 3>who Cried Wolf scenario. People were always submitting articles saying,

1:11:28.080 --> 1:11:29.960
<v Speaker 3>I've found the hepatitis B virus.

1:11:30.080 --> 1:11:30.800
<v Speaker 4>I have found it.

1:11:30.800 --> 1:11:33.400
<v Speaker 3>It's this, It's this kind of like how I feel

1:11:33.439 --> 1:11:36.400
<v Speaker 3>like every few months nowadays, there's an article saying the

1:11:36.520 --> 1:11:38.600
<v Speaker 3>Zodiac killer has finally been identified.

1:11:39.240 --> 1:11:41.320
<v Speaker 4>It's like, okay, let's.

1:11:41.200 --> 1:11:44.040
<v Speaker 3>If we dig a little deeper, like is it true

1:11:44.160 --> 1:11:48.600
<v Speaker 3>or is it not so close to the truth. But

1:11:48.720 --> 1:11:53.000
<v Speaker 3>another reason for the rejection, and this one is much

1:11:53.040 --> 1:11:56.040
<v Speaker 3>more unfair is that Bloomberg and his group were in

1:11:56.160 --> 1:11:59.680
<v Speaker 3>no way part of the hepatitis be seen. They had

1:11:59.720 --> 1:12:02.760
<v Speaker 3>no background and studying hepatitis. None of them had been

1:12:02.800 --> 1:12:07.280
<v Speaker 3>trained as epidemiologists, let alone virologists, so what do they

1:12:07.280 --> 1:12:12.720
<v Speaker 3>know about hepatitis? But despite this initial rejection and the

1:12:12.800 --> 1:12:17.280
<v Speaker 3>resentment from some prominent hepatitis researchers, they managed to get

1:12:17.280 --> 1:12:20.960
<v Speaker 3>a paper published in nineteen sixty seven that awakened the

1:12:21.000 --> 1:12:25.640
<v Speaker 3>world to the possibility that the virus causing transfusion hepatitis,

1:12:26.040 --> 1:12:29.000
<v Speaker 3>the hepatitis B virus, had finally been found.

1:12:29.479 --> 1:12:31.320
<v Speaker 2>Nineteen sixty seven.

1:12:32.200 --> 1:12:32.360
<v Speaker 1>Hm.

1:12:33.080 --> 1:12:37.960
<v Speaker 3>Wow, Yeah, and this seems like an understatement, but this

1:12:38.120 --> 1:12:43.280
<v Speaker 3>was huge news at the time. Post transfusion hepatitis rates

1:12:43.400 --> 1:12:44.559
<v Speaker 3>reached thirty percent.

1:12:45.360 --> 1:12:46.600
<v Speaker 2>Oh my m.

1:12:47.760 --> 1:12:51.320
<v Speaker 3>The beginnings of the incredible prevalence of global hepatitis that

1:12:51.360 --> 1:12:55.719
<v Speaker 3>we have today really does have its roots during this time.

1:12:56.120 --> 1:12:58.559
<v Speaker 3>During this time when there was a lot of blood

1:12:58.560 --> 1:13:01.640
<v Speaker 3>transfusion happening, a lot of blood products being used, a

1:13:01.640 --> 1:13:06.360
<v Speaker 3>lot of needles being reused, without knowing what the virus was,

1:13:06.439 --> 1:13:09.360
<v Speaker 3>how to test for it, how to prevent it. So

1:13:09.400 --> 1:13:14.599
<v Speaker 3>it's yeah, but there was still another step, and that

1:13:14.640 --> 1:13:16.600
<v Speaker 3>was confirmation from other researchers.

1:13:16.880 --> 1:13:18.080
<v Speaker 4>Boom, easily done.

1:13:18.280 --> 1:13:25.720
<v Speaker 3>Check, here's hepatitis be the end almost the end actually,

1:13:27.400 --> 1:13:32.120
<v Speaker 3>the discovery of the hepatitis B virus. This allowed not

1:13:32.200 --> 1:13:35.759
<v Speaker 3>only for the testing of hepatitis B virus and blood products,

1:13:35.840 --> 1:13:39.040
<v Speaker 3>but also the identification of carriers of the virus and

1:13:39.200 --> 1:13:43.679
<v Speaker 3>the eventual development of a vaccine. This isn't to say

1:13:43.680 --> 1:13:47.040
<v Speaker 3>that it was all smooth sailing after the link between

1:13:47.160 --> 1:13:50.439
<v Speaker 3>the Australia antigen and the hepatitis B virus was made.

1:13:51.280 --> 1:13:54.000
<v Speaker 3>For instance, the virus was still not able to be

1:13:54.160 --> 1:13:59.519
<v Speaker 3>maintained in conventional tissue cultures, which made fulfilling Cook's postulates difficult,

1:14:00.280 --> 1:14:02.920
<v Speaker 3>and the test for determining whether or not the virus

1:14:03.040 --> 1:14:06.680
<v Speaker 3>was present pretty insensitive.

1:14:05.960 --> 1:14:06.559
<v Speaker 4>At the time.

1:14:07.000 --> 1:14:10.519
<v Speaker 3>Like I've seen estimates of fifteen to twenty percent of

1:14:10.600 --> 1:14:13.280
<v Speaker 3>the time it would detect hepatitis B virus.

1:14:13.400 --> 1:14:14.439
<v Speaker 2>Yeah, that's pretty bad.

1:14:14.880 --> 1:14:17.600
<v Speaker 3>It's gotten a lot better, we should point out a

1:14:17.640 --> 1:14:24.400
<v Speaker 3>lot yet better, like very good, like excellent. And as

1:14:24.439 --> 1:14:28.160
<v Speaker 3>I always talk about, there's typically this delay from when

1:14:28.240 --> 1:14:30.920
<v Speaker 3>something new is discovered to when there is wide enough

1:14:30.960 --> 1:14:35.240
<v Speaker 3>acceptance for that knowledge to be applied, especially in like

1:14:35.280 --> 1:14:39.680
<v Speaker 3>a medical setting. So screening the blood supply for hepatitis B.

1:14:40.040 --> 1:14:44.400
<v Speaker 3>Even with this you know, pretty poor test didn't start

1:14:44.439 --> 1:14:47.760
<v Speaker 3>for a few years after the virus was discovered, So

1:14:47.840 --> 1:14:51.720
<v Speaker 3>in nineteen seventy the hepatitis B virus tests became official

1:14:51.840 --> 1:14:54.960
<v Speaker 3>in the US, and in nineteen seventy two the American

1:14:54.960 --> 1:14:58.160
<v Speaker 3>Association of Blood Banks had begun to require the testing

1:14:58.200 --> 1:15:02.800
<v Speaker 3>of donors, though the test desperately needed to be improved.

1:15:03.640 --> 1:15:06.679
<v Speaker 3>That was a good start, but being able to test

1:15:06.720 --> 1:15:10.600
<v Speaker 3>for hepatitis B virus also meant that it could identify

1:15:10.680 --> 1:15:14.519
<v Speaker 3>people who were carriers or infected with hepatitis B, which

1:15:14.560 --> 1:15:19.880
<v Speaker 3>then led to widespread discrimination and ostracization for people who

1:15:20.000 --> 1:15:24.040
<v Speaker 3>were positive for appatitis B. People were fired from jobs,

1:15:24.280 --> 1:15:27.599
<v Speaker 3>they were not allowed in classrooms, children were taken off

1:15:27.600 --> 1:15:31.519
<v Speaker 3>adoption lists. People were being denied healthcare from shared machines

1:15:31.560 --> 1:15:33.000
<v Speaker 3>like dialysis machines.

1:15:33.240 --> 1:15:34.040
<v Speaker 4>They were being.

1:15:33.880 --> 1:15:37.120
<v Speaker 3>Denied admittance to medical school or kicked out of their

1:15:37.200 --> 1:15:40.120
<v Speaker 3>jobs as doctors or dentists. I mean, the list goes

1:15:40.200 --> 1:15:43.000
<v Speaker 3>on and on. It was just like, oh, great, we

1:15:43.080 --> 1:15:46.240
<v Speaker 3>have this test, we can help prevent hepatitis and also

1:15:46.880 --> 1:15:50.519
<v Speaker 3>we can put the scarlet letter of hepatitis on every

1:15:50.560 --> 1:15:51.759
<v Speaker 3>single person that we test.

1:15:52.840 --> 1:15:57.200
<v Speaker 2>I feel like that part of hepatitis B especially is

1:15:57.320 --> 1:16:04.960
<v Speaker 2>so overlooked today. Hmm, Like yeah, yeah.

1:16:03.960 --> 1:16:06.920
<v Speaker 3>And yeah, a lot of these many or most of

1:16:06.960 --> 1:16:11.759
<v Speaker 3>these restrictions or regulations have been overturned, but the stigma

1:16:11.840 --> 1:16:15.800
<v Speaker 3>and isolation faced by many people with hepatitis B continues

1:16:15.840 --> 1:16:20.160
<v Speaker 3>today and has a huge detrimental impact on their quality

1:16:20.160 --> 1:16:24.800
<v Speaker 3>of life. Right after the hepatitis B virus was identified,

1:16:25.080 --> 1:16:28.959
<v Speaker 3>many people began working on a hepatitis B vaccine, including

1:16:29.040 --> 1:16:32.559
<v Speaker 3>Bloomberg and his colleague doctor Irving Millman, who came out

1:16:32.600 --> 1:16:35.719
<v Speaker 3>with one in nineteen sixty nine, and over the next

1:16:35.760 --> 1:16:39.000
<v Speaker 3>decade people would work on refining the vaccine and incorporating

1:16:39.080 --> 1:16:42.479
<v Speaker 3>it into routine vaccine schedules. And I think since then

1:16:42.479 --> 1:16:45.519
<v Speaker 3>it's kind of faced like continuous like tweaking, and we've

1:16:45.560 --> 1:16:49.760
<v Speaker 3>gotten a pretty solid, from my understanding, hepatitis B vaccine.

1:16:50.400 --> 1:16:50.639
<v Speaker 1>Yeah.

1:16:50.640 --> 1:16:54.240
<v Speaker 2>Since nineteen eighty one was when the hepatitis BA vaccine

1:16:54.280 --> 1:16:58.559
<v Speaker 2>was licensed like in the US widespread by the FDA,

1:16:58.680 --> 1:17:01.559
<v Speaker 2>and then nineteen eighty six it was updated to not

1:17:01.680 --> 1:17:08.320
<v Speaker 2>have any like human parts in it. Essentially, it's made

1:17:08.360 --> 1:17:11.719
<v Speaker 2>in a yeast and it's a real combinant vaccine, and

1:17:11.800 --> 1:17:13.720
<v Speaker 2>as far as I know, it's the same vaccine since

1:17:13.800 --> 1:17:14.679
<v Speaker 2>nineteen eighty six.

1:17:15.240 --> 1:17:18.719
<v Speaker 3>Do you know who helped work on the yeast aspect

1:17:18.760 --> 1:17:19.120
<v Speaker 3>of it?

1:17:19.160 --> 1:17:20.200
<v Speaker 2>Tell me who erin?

1:17:21.520 --> 1:17:24.439
<v Speaker 3>Maurice Hillman are Oh, let's hear it for Maurice.

1:17:24.640 --> 1:17:26.599
<v Speaker 4>He's here for Maurice.

1:17:26.680 --> 1:17:30.160
<v Speaker 3>And I already mentioned one person in this story who

1:17:30.479 --> 1:17:33.200
<v Speaker 3>was the recipient of a Nobel Prize for their work

1:17:33.280 --> 1:17:36.679
<v Speaker 3>on hepatitis viruses, and that was in twenty twenty.

1:17:36.760 --> 1:17:37.800
<v Speaker 4>But in nineteen.

1:17:37.520 --> 1:17:41.880
<v Speaker 3>Seventy six, doctor Brooke Bloomberg was awarded the Nobel Prize

1:17:41.920 --> 1:17:45.400
<v Speaker 3>in Physiology or Medicine for his work and identifying the

1:17:45.400 --> 1:17:46.800
<v Speaker 3>hepatitis B virus.

1:17:47.240 --> 1:17:47.639
<v Speaker 2>Love it.

1:17:48.600 --> 1:17:51.920
<v Speaker 3>Also that same year it was co awarded to two

1:17:51.960 --> 1:17:54.599
<v Speaker 3>different people, just to you know, that didn't have any

1:17:54.960 --> 1:18:00.160
<v Speaker 3>work together. The other person awarded was Carlton Gadgasek. You

1:18:00.160 --> 1:18:03.280
<v Speaker 3>remember him from Preon's The Bad Guy.

1:18:03.400 --> 1:18:08.760
<v Speaker 2>Yes, yes, I do, uh huh.

1:18:08.920 --> 1:18:13.240
<v Speaker 3>Over the decades since the discovery of the hepatitis B virus,

1:18:13.760 --> 1:18:18.280
<v Speaker 3>there's been a great deal of research on understanding transmission dynamics,

1:18:18.439 --> 1:18:23.120
<v Speaker 3>genotype differences, the cancer causing potential of the hepatitis B virus.

1:18:23.560 --> 1:18:28.600
<v Speaker 3>New hepatitis viruses like hepatitis D, like hepatitis C, like

1:18:28.640 --> 1:18:34.120
<v Speaker 3>hepatitis E, better blood tests, improved vaccines, harm reduction programs,

1:18:34.400 --> 1:18:38.160
<v Speaker 3>and a growing recognition of the tremendous global burden that

1:18:38.240 --> 1:18:42.000
<v Speaker 3>this virus has in a physical, economic, and emotional sense.

1:18:43.120 --> 1:18:46.160
<v Speaker 3>And despite all of the advancements made in the field

1:18:46.200 --> 1:18:51.559
<v Speaker 3>of hepatitis B research, the virus is still extraordinarily prevalent

1:18:52.200 --> 1:18:59.479
<v Speaker 3>and transmission continues today. So, Aaron, that was kind of

1:18:59.520 --> 1:19:04.120
<v Speaker 3>a quick wrap up to the future. But I want

1:19:04.160 --> 1:19:07.680
<v Speaker 3>to hear where we stand with hepatitis B today. So

1:19:08.120 --> 1:19:08.880
<v Speaker 3>can you fill me in?

1:19:09.360 --> 1:19:45.160
<v Speaker 2>Oh, I can't wait to right after this break. Unlike

1:19:45.200 --> 1:19:50.720
<v Speaker 2>our first three episodes, I have some a lot of

1:19:50.760 --> 1:19:55.920
<v Speaker 2>statistics for this section, Aaron, first three episodes of this season,

1:19:55.960 --> 1:20:02.559
<v Speaker 2>I mean, but they're pretty sobering. Okay. Globally, it is

1:20:02.680 --> 1:20:09.000
<v Speaker 2>estimated that close to four percent of the entire world's

1:20:09.240 --> 1:20:16.640
<v Speaker 2>population is living with chronic hepatitis B infection. That is

1:20:16.760 --> 1:20:24.280
<v Speaker 2>close to three hundred million human beings. And believe it

1:20:24.360 --> 1:20:27.320
<v Speaker 2>or not, that's an improvement because the very first paper

1:20:27.360 --> 1:20:29.759
<v Speaker 2>I read was a bit older, from two thousand and four,

1:20:29.960 --> 1:20:33.280
<v Speaker 2>and that started off by saying, over four hundred million people,

1:20:33.960 --> 1:20:35.679
<v Speaker 2>So we're down.

1:20:36.000 --> 1:20:38.880
<v Speaker 4>So those are people chronically infected.

1:20:38.920 --> 1:20:41.599
<v Speaker 2>Right, living with chronic hepatitis being and how.

1:20:41.520 --> 1:20:44.400
<v Speaker 3>Many people are infected newly every year?

1:20:44.520 --> 1:20:48.960
<v Speaker 2>What's the The World Health Organization estimates one point five

1:20:49.160 --> 1:20:57.719
<v Speaker 2>million people are newly infected every year. Wow. Yes, it's horrific.

1:20:58.479 --> 1:21:01.840
<v Speaker 2>If we look at the entire spectrum or the whole

1:21:01.880 --> 1:21:09.160
<v Speaker 2>alphabet of hepatida or viral hepatitis is viral hepatitis caused

1:21:09.400 --> 1:21:15.439
<v Speaker 2>an estimated one point three four million deaths in twenty

1:21:15.560 --> 1:21:21.560
<v Speaker 2>fifteen alone, which is more than HIV. It is substantially

1:21:21.640 --> 1:21:25.840
<v Speaker 2>more than malaria, and it's nearly as much as tuberculosis.

1:21:26.280 --> 1:21:29.360
<v Speaker 4>So why does it feel like it's not talked about?

1:21:30.160 --> 1:21:30.400
<v Speaker 1>Why?

1:21:30.680 --> 1:21:34.400
<v Speaker 2>Erin, I don't know, Okay, And that's all of the

1:21:34.479 --> 1:21:41.160
<v Speaker 2>viral hepatitis hepatidi Okay. Of all of those deaths, ninety

1:21:41.240 --> 1:21:45.880
<v Speaker 2>six percent are estimated to be from chronic hepatitis. And

1:21:46.120 --> 1:21:49.960
<v Speaker 2>of that ninety six percent, sixty six percent of those

1:21:50.040 --> 1:21:53.960
<v Speaker 2>are from hepatitis B. So if we do some erin math,

1:21:54.479 --> 1:21:57.280
<v Speaker 2>just kidding, just kidding, the World Health Organization did this

1:21:57.400 --> 1:22:04.280
<v Speaker 2>that that is eight hundred and twenty thousand humans that

1:22:04.320 --> 1:22:13.800
<v Speaker 2>are dying from chronic hepatitis B infection every single year. Ah.

1:22:14.640 --> 1:22:18.120
<v Speaker 2>Now you asked why we're not talking about it. Yeah,

1:22:18.120 --> 1:22:21.040
<v Speaker 2>here's probably a large part of it. That burden is

1:22:21.200 --> 1:22:25.040
<v Speaker 2>not born equally across the globe, of course not. The

1:22:25.080 --> 1:22:30.040
<v Speaker 2>World Health Organization, you know, divides the globe into different regions.

1:22:30.920 --> 1:22:35.040
<v Speaker 2>The Western Pacific region by far has the highest incidents

1:22:35.040 --> 1:22:38.439
<v Speaker 2>and prevalence of hepatitis BE, followed by the World Health

1:22:38.520 --> 1:22:42.599
<v Speaker 2>Organization African region. And in these areas the prevalence can

1:22:42.640 --> 1:22:47.160
<v Speaker 2>be as high as six percent or greater in some cases, wow,

1:22:47.360 --> 1:22:49.960
<v Speaker 2>oh my gosh, whereas in some parts of the world,

1:22:50.080 --> 1:22:52.599
<v Speaker 2>like in Europe or in North America, the prevalence may

1:22:52.640 --> 1:22:56.000
<v Speaker 2>be less than one percent. And so I think that

1:22:56.680 --> 1:23:02.400
<v Speaker 2>huge global discrepancy can lead for some countries to not

1:23:02.520 --> 1:23:05.000
<v Speaker 2>think a lot or talk a lot about hepatitis B.

1:23:05.400 --> 1:23:08.320
<v Speaker 4>Yeah, it's oh, well, it's not a problem here, so.

1:23:10.280 --> 1:23:17.599
<v Speaker 2>Exactly, Aaron, I think I wrote those exact words later on. Yeah,

1:23:17.800 --> 1:23:21.800
<v Speaker 2>And it gets more sobering because it's also estimated that

1:23:21.880 --> 1:23:26.880
<v Speaker 2>only ten percent ten and a half percent of people

1:23:26.920 --> 1:23:32.280
<v Speaker 2>that are living with hepatitis B know their status. And

1:23:32.360 --> 1:23:35.479
<v Speaker 2>it's also estimated that only twenty two percent of those

1:23:35.920 --> 1:23:39.400
<v Speaker 2>that are diagnosed that know their status are on treatment

1:23:39.479 --> 1:23:42.800
<v Speaker 2>for chronic hepatitis. Be that statistic I want you to

1:23:42.880 --> 1:23:46.360
<v Speaker 2>take with a grain of salt, because not everyone who

1:23:46.400 --> 1:23:50.000
<v Speaker 2>is diagnosed with chronic hepatitis B necessarily needs treatment, at

1:23:50.080 --> 1:23:53.639
<v Speaker 2>least not right away, So that statistic at least might

1:23:53.680 --> 1:23:56.840
<v Speaker 2>not be quite as bad as it sounds. But ten

1:23:56.920 --> 1:24:00.280
<v Speaker 2>percent of people knowing their status is pretty bad.

1:24:00.920 --> 1:24:04.000
<v Speaker 4>Yeah, that's I mean, that's yeah.

1:24:04.800 --> 1:24:10.439
<v Speaker 2>Yeah, it's also I have more numbers as a number

1:24:10.479 --> 1:24:15.839
<v Speaker 2>heavy one and these numbers are from a modeling study

1:24:15.880 --> 1:24:21.360
<v Speaker 2>from twenty sixteen data. But of this almost four percent

1:24:21.439 --> 1:24:24.840
<v Speaker 2>of the global population that is infected with chronic hepatitis B,

1:24:26.080 --> 1:24:29.160
<v Speaker 2>between one point six to two point two million are

1:24:29.240 --> 1:24:33.800
<v Speaker 2>children under the age of five, and the World Health

1:24:33.880 --> 1:24:38.000
<v Speaker 2>Organization most recent data does suggest that it's now finally

1:24:38.560 --> 1:24:42.800
<v Speaker 2>just under one percent of all children worldwide under age

1:24:42.800 --> 1:24:46.400
<v Speaker 2>five that are chronically infected. That's down from around five

1:24:46.520 --> 1:24:50.200
<v Speaker 2>percent of all children in the pre vaccine era. Oh

1:24:50.240 --> 1:24:55.559
<v Speaker 2>my gosh, I know, and still like just under one percent,

1:24:55.800 --> 1:25:00.840
<v Speaker 2>essentially one percent of all kids under age five globally

1:25:01.400 --> 1:25:06.120
<v Speaker 2>living with this chronic infection that I can't emphasize enough

1:25:06.760 --> 1:25:12.280
<v Speaker 2>is entirely preventable At this point. We have had a

1:25:12.400 --> 1:25:16.439
<v Speaker 2>vaccine for hepatitis B that is ninety eight to one

1:25:16.520 --> 1:25:23.320
<v Speaker 2>hundred percent effective for seventeen to thirty years, like not

1:25:23.520 --> 1:25:29.520
<v Speaker 2>a lot of waning immunity, incredibly effective vaccine for forty years.

1:25:29.920 --> 1:25:32.240
<v Speaker 4>So I have a question about that.

1:25:32.720 --> 1:25:37.080
<v Speaker 3>So is it part of every single routine vaccine schedule.

1:25:37.560 --> 1:25:41.160
<v Speaker 2>Over one hundred and eighty countries have hepatitis B as

1:25:41.200 --> 1:25:45.320
<v Speaker 2>part of their universal vaccine program, and it's estimated that

1:25:45.479 --> 1:25:50.679
<v Speaker 2>eighty seven percent of infants worldwide received the three dose

1:25:51.560 --> 1:25:54.960
<v Speaker 2>B vaccine series in their first year of life, which

1:25:55.000 --> 1:25:59.800
<v Speaker 2>is great, but only forty six percent likely had a

1:25:59.840 --> 1:26:06.360
<v Speaker 2>timely birth vaccination that critical twelve to twenty four hour window,

1:26:06.880 --> 1:26:11.320
<v Speaker 2>and even less, this study estimated about thirteen percent got

1:26:11.479 --> 1:26:15.920
<v Speaker 2>both the hepatitis B vaccine and if needed, that IVIG

1:26:16.120 --> 1:26:21.720
<v Speaker 2>to actually treat and provide more passive immunity. But with

1:26:22.040 --> 1:26:26.639
<v Speaker 2>IVIG and the vaccine within twelve to twenty four hours

1:26:26.680 --> 1:26:30.080
<v Speaker 2>of birth, it's still about ninety one percent effective to

1:26:30.240 --> 1:26:35.400
<v Speaker 2>prevent B infection in those babies. But it's even more

1:26:35.520 --> 1:26:39.000
<v Speaker 2>effective if you can treat the pregnant person to lower

1:26:39.040 --> 1:26:43.240
<v Speaker 2>their viral load. Okay, And it's estimated that only about

1:26:43.280 --> 1:26:46.799
<v Speaker 2>one percent of pregnant people are actually getting that testing

1:26:46.840 --> 1:26:52.800
<v Speaker 2>and then treatment one percent. Yeah, one percent or less,

1:26:54.120 --> 1:26:58.320
<v Speaker 2>And so that contributes a lot to the overall burden

1:26:58.360 --> 1:27:00.800
<v Speaker 2>and why we still have such high infection rates.

1:27:02.160 --> 1:27:04.000
<v Speaker 4>We have the tools, just not the delivery.

1:27:04.560 --> 1:27:08.400
<v Speaker 2>Yeah, so we have a lot of improvements to still

1:27:08.560 --> 1:27:09.520
<v Speaker 2>be made.

1:27:09.760 --> 1:27:10.680
<v Speaker 4>Yeah.

1:27:10.720 --> 1:27:18.320
<v Speaker 2>Overall, this is a massive, massive disease. I honestly didn't

1:27:18.320 --> 1:27:21.480
<v Speaker 2>even realize how massive it was before researching for this episode.

1:27:21.960 --> 1:27:25.759
<v Speaker 2>And because it's such an enormous global problem, I'm glad

1:27:25.800 --> 1:27:28.200
<v Speaker 2>that we were able to highlight so many different parts

1:27:28.200 --> 1:27:32.200
<v Speaker 2>of this really important disease. But there are still several

1:27:32.200 --> 1:27:35.800
<v Speaker 2>aspects that we didn't fully cover in this episode, especially

1:27:36.000 --> 1:27:39.840
<v Speaker 2>the substantial stigma and discrimination faced by so many people

1:27:39.880 --> 1:27:41.799
<v Speaker 2>living with hepatitis BE around the world.

1:27:42.280 --> 1:27:45.840
<v Speaker 3>Right, And because this is such an important part of

1:27:45.880 --> 1:27:49.400
<v Speaker 3>the hepatitis B story, I am so excited to be

1:27:49.439 --> 1:27:51.760
<v Speaker 3>able to take a deeper dive into it in a

1:27:51.800 --> 1:27:54.400
<v Speaker 3>bonus episode coming out next week.

1:27:54.439 --> 1:27:58.120
<v Speaker 2>Woo oooh, you heard that right, bonus episode.

1:27:58.640 --> 1:28:02.160
<v Speaker 3>So I enlisted the help of the amazing doctor Sherry Cohen,

1:28:02.200 --> 1:28:05.240
<v Speaker 3>who is senior vice president of the Hepatitis B Foundation,

1:28:05.880 --> 1:28:08.800
<v Speaker 3>to discuss some of the drivers of stigma and discrimination

1:28:08.920 --> 1:28:12.320
<v Speaker 3>in hepatitis B and what's being done about it. I

1:28:12.360 --> 1:28:15.400
<v Speaker 3>also got to pick doctor Cohen's brain about what it's

1:28:15.479 --> 1:28:18.720
<v Speaker 3>like to work in the public health nonprofit world, what

1:28:18.760 --> 1:28:21.920
<v Speaker 3>the differences between a doctor of public health and a

1:28:21.920 --> 1:28:26.240
<v Speaker 3>PhD is, and some fantastic advice for people who might

1:28:26.280 --> 1:28:28.960
<v Speaker 3>be interested in pursuing a career in public health.

1:28:29.200 --> 1:28:31.040
<v Speaker 2>And we know there's a lot of you out there.

1:28:31.160 --> 1:28:32.360
<v Speaker 4>There's a lot of you out there.

1:28:32.479 --> 1:28:36.040
<v Speaker 3>Yes, it was so much fun chatting with doctor Cohen,

1:28:36.080 --> 1:28:38.960
<v Speaker 3>and you should definitely mark your calendars so you don't

1:28:39.000 --> 1:28:43.559
<v Speaker 3>miss the app. It comes out next Tuesday, February first. Okay,

1:28:43.800 --> 1:28:47.200
<v Speaker 3>but should we maybe wrap up this episode for now?

1:28:47.400 --> 1:28:51.920
<v Speaker 2>I think we should time for sources. It is a right.

1:28:53.080 --> 1:28:57.400
<v Speaker 3>So I have a lot of papers for this, and

1:28:57.600 --> 1:28:59.479
<v Speaker 3>I'll post them all on our website, But I do

1:28:59.520 --> 1:29:01.880
<v Speaker 3>want to shout that one book in particular, and that is,

1:29:01.920 --> 1:29:04.920
<v Speaker 3>of course, Hepatitis B The Hunt for a Killer Virus

1:29:05.280 --> 1:29:06.880
<v Speaker 3>by doctor Bruke Blumberg.

1:29:07.640 --> 1:29:10.880
<v Speaker 2>I have a few papers, not as many for this

1:29:11.000 --> 1:29:14.519
<v Speaker 2>as some episodes, but a few really nice review papers.

1:29:15.240 --> 1:29:17.280
<v Speaker 2>Most of them are from the Lancet and they've just

1:29:17.320 --> 1:29:20.080
<v Speaker 2>been like updates on each other. So the most recent

1:29:20.080 --> 1:29:22.200
<v Speaker 2>one that I read was published in twenty eighteen and

1:29:22.240 --> 1:29:25.639
<v Speaker 2>called Chronic Hepatitis B Virus Infection has a lot more

1:29:25.680 --> 1:29:29.240
<v Speaker 2>detail about the different phases of chronic infection. And we'll

1:29:29.280 --> 1:29:32.400
<v Speaker 2>post the sources for this episode and every one of

1:29:32.400 --> 1:29:34.960
<v Speaker 2>our episodes on our website. This podcast will kill you

1:29:34.960 --> 1:29:36.759
<v Speaker 2>dot com. We sure will.

1:29:37.920 --> 1:29:41.320
<v Speaker 3>A big thank you again to doctor Wong for taking

1:29:41.320 --> 1:29:44.160
<v Speaker 3>the time to chat with us and being willing to

1:29:44.200 --> 1:29:47.559
<v Speaker 3>share your experiences with hepatitis B. And also thanks for

1:29:47.600 --> 1:29:48.720
<v Speaker 3>all the awesome work you do.

1:29:49.360 --> 1:29:53.240
<v Speaker 2>Yeah, thank you so much. Thank you also to Bloodmobile

1:29:53.320 --> 1:29:55.519
<v Speaker 2>for providing the music for this episode and all of

1:29:55.520 --> 1:29:56.800
<v Speaker 2>our episodes.

1:29:56.479 --> 1:29:58.880
<v Speaker 3>And thank you too, exactly right of whom we are

1:29:58.960 --> 1:30:00.360
<v Speaker 3>a very proud member.

1:30:01.120 --> 1:30:04.960
<v Speaker 2>And thank you of course to you listeners. We love

1:30:05.040 --> 1:30:07.640
<v Speaker 2>making this podcast and we couldn't do it if you

1:30:07.640 --> 1:30:09.360
<v Speaker 2>didn't listen to it.

1:30:09.320 --> 1:30:10.479
<v Speaker 4>That's very true.

1:30:11.160 --> 1:30:13.919
<v Speaker 3>And also an extra big thank you as.

1:30:13.720 --> 1:30:17.360
<v Speaker 4>Always to our wonderful patrons. We love you. You're amazing,

1:30:17.640 --> 1:30:18.200
<v Speaker 4>We love it.

1:30:19.240 --> 1:30:22.400
<v Speaker 3>Okay, Well, until next time, wash your hands

1:30:22.640 --> 1:30:23.800
<v Speaker 2>You filthy animals.